STOCK TITAN

Axon (NASDAQ: AXON) sets 2026 virtual vote, highlights 33% growth and AI strategy

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
DEF 14A

Rhea-AI Filing Summary

Axon Enterprise, Inc. is asking shareholders to vote at its fully virtual 2026 annual meeting on May 28, 2026, on three items: electing directors, an advisory vote on executive pay, and ratifying PricewaterhouseCoopers as auditor for 2026.

The proxy highlights Axon’s strategy as an AI‑driven, integrated hardware and software platform spanning TASER devices, cameras, cloud evidence, real‑time operations and 911 solutions. For 2025, Axon reports record revenue of $2.8 billion, up 33%, its fourth straight year above 30% growth, with Software & Services now 43% of revenue, annual recurring revenue of $1.3 billion, and net revenue retention of 125%.

Net income was $125 million (4.5% margin) and adjusted EBITDA was $710 million (25.5% margin), while bookings reached $7.4 billion, up 46%. The board stresses independent leadership, majority voting for directors, proxy access, refreshed tenure and term limits, and expanded oversight of ESG, cybersecurity and AI.

Positive

  • None.

Negative

  • None.
2025 Revenue $2.8 billion Record full-year 2025 revenue, up 33% year over year
Annual Bookings $7.4 billion 2025 bookings, up 46% year over year
Net Income $125 million 2025 net income, 4.5% net margin
Adjusted EBITDA $710 million 2025 adjusted EBITDA, 25.5% margin
Annual Recurring Revenue $1.3 billion ARR in 2025
Net Revenue Retention 125% 2025 net revenue retention
Software & Services Mix 43% of revenue Software & Services share of 2025 revenue
Shares Outstanding 80,572,201 shares Common stock outstanding as of March 31, 2026
adjusted EBITDA financial
"We delivered net income of $125 million at a 4.5% margin and adjusted EBITDA of $710 million at a 25.5% margin"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
annual recurring revenue (ARR) financial
"ARR reached $1.3 billion. Net revenue retention accelerated to 125%."
Annual Recurring Revenue (ARR) is the predictable amount of money a company expects to earn in a year from its ongoing services or subscriptions. It helps businesses understand their steady income stream, much like knowing how much rent they can count on each year, which is important for planning and growth.
net revenue retention financial
"ARR reached $1.3 billion. Net revenue retention accelerated to 125%."
Net revenue retention measures how much revenue a company keeps from its existing customers over a set period after accounting for customers who leave, reductions in spending, and any increases from upsells or cross-sells. For investors it shows whether a company can grow sales from the customers it already has—like checking whether a store is making more or less money from its regular shoppers—which signals business health and future revenue durability.
Rule of 40 financial
"while maintaining a Rule of 40 above 55—and we did it while investing aggressively"
The "rule of 40" is a simple guideline used by investors to assess the health of a company's growth and profitability. It adds a company's growth rate to its profit margin; if the total is 40% or higher, the company is generally considered to be performing well. This helps investors quickly gauge whether a company is balancing rapid growth with solid profits, much like checking if a car’s speed and fuel efficiency together are within a safe and efficient range.
proxy access regulatory
"Regular shareholder engagement with our investors to understand their views and seek feedback • “Proxy access” bylaw provision"
Proxy access allows shareholders to include their nominated directors on a company’s official proxy ballot and meeting materials, instead of running separate, costly campaigns. It matters to investors because it makes it easier for shareholders to push for board change, hold management accountable, and influence strategy—similar to getting your preferred candidate listed on a neighborhood ballot rather than having to start an independent petition drive.
majority voting standard regulatory
"Our Bylaws provide that we use a majority voting standard instead of a plurality voting standard in uncontested elections."
Key Proposals
  • Election of the directors of the Company named in the proxy statement
  • Advisory vote to approve the compensation of the Company’s named executive officers
  • Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026
0001069183FALSEDEF 14Aiso4217:USD00010691832025-01-012025-12-3100010691832024-01-012024-12-3100010691832023-01-012023-12-3100010691832022-01-012022-12-3100010691832021-01-012021-12-310001069183ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMemberecd:PeoMember2025-01-012025-12-310001069183ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMemberecd:NonPeoNeoMember2025-01-012025-12-310001069183ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecd:PeoMember2025-01-012025-12-310001069183ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMemberecd:NonPeoNeoMember2025-01-012025-12-310001069183ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecd:PeoMember2025-01-012025-12-310001069183ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMemberecd:NonPeoNeoMember2025-01-012025-12-310001069183ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecd:PeoMember2025-01-012025-12-310001069183ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMemberecd:NonPeoNeoMember2025-01-012025-12-310001069183ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecd:PeoMember2025-01-012025-12-310001069183ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMemberecd:NonPeoNeoMember2025-01-012025-12-310001069183ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMemberecd:PeoMember2025-01-012025-12-310001069183ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMemberecd:NonPeoNeoMember2025-01-012025-12-31000106918312025-01-012025-12-31000106918322025-01-012025-12-31000106918332025-01-012025-12-31
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.    )
_________________________________________________________
Filed by the Registrant x
Filed by a Party other than the Registrant o
Check the appropriate box:
o
Preliminary Proxy Statement
o
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
x
Definitive Proxy Statement
o
Definitive Additional Materials
o
Soliciting Material Pursuant to §240.14a-12
Axon Enterprise, Inc.
(Name of Registrant as Specified In Its Charter)
_________________________________________________________
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
x
No fee required.
o
Fee paid previously with preliminary materials.
o
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11
Table of Contents
A Letter from Axon CEO, Rick Smith
Fellow Shareholders,
I have been building this company for over 30 years. I have never been more energized—or more convinced that the
moment we are in will define a generation.
The world is changing faster than at any point in my career. Artificial intelligence (“AI”) is not an incremental advance. It
is a fundamental disruption—a force that will reshape industries, redefine what technology can do, and break companies
that are not ready for it. At the same time, the problems we set out to solve three decades ago—violence, injustice, a lack of
accountability—remain as urgent as ever.
These two realities are converging, and Axon sits at the intersection. Our mission to protect life has always demanded
imagination—the willingness to invent new solutions when the world said none existed. Now, for the first time, the
technology is advancing fast enough to match the scale of that ambition. What once felt like a distant aspiration is
becoming operational reality, and it is happening faster than any of us anticipated.
2025 was the year that came into focus. We delivered the strongest results in our history—not by playing it safe, but by
leaning in. And it starts with the reason we exist.
Our Moonshot: The First Signs of Progress
A few years ago, we set an audacious goal: cut gun-related deaths between police and the public in the U.S. in half by
2033. In 2025, for the first time, the trend line moved in the right direction—fatalities declined nearly 10% from their peak.
It is too early to claim direct causation, but we are hearing from customers every day about situations where officers
reached for their TASER device instead of their firearm, and a life was saved as a result. A major U.S. county sheriff's
office reported a 42% reduction in deputy-involved shootings, crediting TASER 10 and de-escalation training delivered
through our Virtual Reality (“VR”) platform as contributing factors.
This is not only about our latest TASER device getting into the hands of more people. We can build the greatest device
ever created, but if people are not trained to use it effectively, it does not deliver its true value. That is why we invested in
building a suite of VR training solutions over the past five years—leaning in before VR was common or widely adopted.
Last year, customers completed nearly half a million VR training sessions, and our platform is now one of the most widely
deployed in U.S. public safety. This year, we are infusing it with AI-powered features that will transform how officers are
trained in the decade ahead.
We lean in and make bold bets before it is safe to do so—that’s how we build our first-mover advantage. We believe that
advantage will compound over time—and the AI Era is here to prove that.
The AI Era Is Here And Axon Is Built for It
We are living through a pivotal moment—not just for Axon, not just for public safety, but for humanity. This is the
moment where human and machine intelligence begin working together to solve problems that once felt permanent.
The world sees the risk AI poses to traditional software—but Axon is not just software. We are an integrated hardware and
software ecosystem, powered by massive real-world data, deployed in high-regulation environments, and—most
importantly—built on deep trust with customers who depend on us as their technology partner. That combination is
extraordinarily difficult to replicate, and it is why I believe AI is the greatest accelerant Axon has ever had.
Our differentiation is not the models—everyone has access to frontier models. It is the physical sockets already on the
officer: the body cameras, TASER devices, and sensors that hundreds of thousands of professionals wear every day. We do
not need to convince anyone to carry a new device. We embed AI directly into the tools they already depend on. Behind
those sockets sits some of the most sensitive operational data on earth, managed on our Evidence.com platform with the
highest standards of privacy and security. And connecting it all are the real-world workflows—records, reports, evidence
sharing, real-time operations—where AI unlocks value at every layer.
Table of Contents
Just months after launch, more than 500 agencies went live on Axon Assistant, with officers translating conversations in
50+ languages, querying policy hands-free, and producing reports in a fraction of the time—all through the body cameras
they already wear. We are just getting started with what that assistant can do—and it is going to be exponentially more
powerful over just another few months.
Our strategy is resonating with our customers. In our first full year with our AI Era Plan—the package and the promise that
we have made to customers—we booked approximately $750 million. That’s beyond the rate of any individual software
product we’ve shipped to date, and well ahead of our expectations. It’s a sign that our customers trust us to be there for
them, and they trust us to show them the way.
My conviction is that nobody should be more aggressive or more thoughtful on AI than Axon. If we get that balance right,
we will not just be a vendor. We will be the partner our customers cannot imagine operating without. That is when the real
flywheel kicks in—deeper relationships, expanded footprints, and increasingly mission-critical problems landing on our
doorstep.
Building the World's Leading Safety Sensor Network
Our vision can be stated simply: the world's leading safety sensor network, fully connected and supercharged by AI.
Today, a TASER 10 cartridge is fired approximately every 30 seconds in the U.S. Our body cameras have recorded over 60
million hours of footage. Fusus powers more than one million monthly livestreams across 300,000+ connected community
cameras. Each data point is a node in a network that grows more connected and more intelligent every day—and every new
sensor, every new workflow, and every new customer makes the whole platform more valuable.
In 2025, we expanded that network significantly. Axon Vehicle Intelligence brought us into the fixed license plate reading
market—integrating live streaming, real-time alerts, and AI-powered vehicle descriptors into a unified workflow. Axon
Body Mini extends our ecosystem into commercial environments—retail, healthcare, logistics—with a compact, connected,
AI-powered camera purpose-built for enterprise workers.
And with our acquisitions of Prepared and Carbyne, Axon 911 extends the ecosystem to the very first moment a call for
help is made, connecting AI-enabled communications to the sensors, real-time operations, and documentation workflows
already in our network.
A decade ago, I saw pressure to shed our hardware businesses and chase software margins. I disagreed. My belief was and
remains that the most important customer problems require integrated solutions—not point products. What we have built is
an interconnected ecosystem of hardware, software, and cloud services embedded in heavily regulated industries through
long-term contracts.
Rather than being a target for disruption, we are the disruptor. We remain focused on our customers and where their needs
are not met, and that’s what leads us to disrupt existing workflows from so many angles. The current environment is
accelerating ability to do this at scale and we seek to build the platform our customers will trust to scale with them.
That focus won’t be replicated in pieces, and a vision is difficult to follow without being willing to take a risk and pioneer
it.
Protecting Life in More Places
Our ecosystem is not built for one use case. It is built for every environment where safety, documentation, and
accountability matter—and where technology has lagged for decades.
A correctional officer with the tools to de-escalate before conflict starts. A retail associate trained through immersive AI
scenarios, equipped with a body camera that connects them to their security team in seconds, with incidents automatically
summarized and transmitted to the appropriate response. A healthcare worker whose documentation burden drops so she
can focus on the patient in front of her. A federal agent with the same integrated platform as the local officer on the beat. A
prosecutor who walks into court with a clear, evidence-based picture of exactly what happened.
The platform is the same. The impact scales to every corner of public safety—and now beyond.
Table of Contents
What excites me most is this: we are not building for just one of these futures. We are building for all of them. Every
critical incident follows three phases—observe, communicate, and act. Our sensors capture what is happening. Our
connected platform shares it in real time. And AI embedded natively in every workflow helps our customers act with
greater speed, clarity, and confidence. This is the difference between technology that assists and technology that
transforms. We are giving our customers genuine superpowers—the ability to do things that simply were not possible
before.
Results That Reflect Execution
Our mission is delivering financial results that match our ambition. Axon achieved record revenue of $2.8 billion in 2025,
up 33% year over year, our fourth consecutive year of annual growth above 30%. Software & Services grew over 40% and
now represents 43% of revenue. ARR reached $1.3 billion. Net revenue retention accelerated to 125%.
We delivered net income of $125 million at a 4.5% margin and adjusted EBITDA of $710 million at a 25.5% margin while
maintaining a Rule of 40 above 55—and we did it while investing aggressively in R&D, new product categories, and go-to-
market expansion.
These metrics measure our past execution, but they also excite me for our future. With only about 30% of customers on
premium subscription plans today, the runway ahead is substantial. We have set our strongest outlook ever heading into
2026, and our long-term targets reflect our confidence that we are still in the early innings of what this ecosystem can
become.
Let's Roll
Darwin got it right: it is not the strongest who survive, but the most adaptable. Axon has always been built on reinvention
—finding a way forward when others said there was none. That is not just our history. It is our competitive advantage.
Complacency is fatal. Pulling back would assure failure. Leaning in creates the future. We are taking bold risks, investing
aggressively, and reimagining everything AI can touch in our domain—while staying grounded in the mission and values
that have defined us from the start.
I have been doing this for over 30 years. I have never been more energized than I am right now. What I see inside this
company—teams delivering multiples of their original roadmaps, creativity accelerating at a pace I have never witnessed—
tells me we are in the right position at the right moment.
To our employees, customers, and shareholders—thank you for believing in what we are building. We are not just building
a business. We are solving problems that matter.
Let's roll.
-Rick
Table of Contents
BUSINESS HIGHLIGHTS
Who We Are
Axon Enterprise, Inc. (“Axon,” the “Company,” “we” or “us”) is a technology company that provides integrated hardware
and software solutions. Founder-led since 1993, Axon began with a mission to protect life and has grown into a global
technology company serving a range of customers. Our products and services allow customers across the public and private
sector to capture and use critical data to support fully-connected operational workflows. Our trusted network seamlessly
integrates software and hardware with a range of connected devices, including TASER energy devices, cameras and
sensors, drones and robotics, cloud-based evidence management, records management, real-time operations software,
critical incident and emergency response systems, immersive training, and productivity tools – all enhanced by artificial
intelligence (“AI”). Designed to work together, these solutions create a unified, data-driven operating system that
prioritizes safety and helps protect people and places with greater speed, accuracy, transparency, and accountability.
Our integrated technology platform of hardware and software solutions advances our mission to (i) make the bullet
obsolete, (ii) reduce social conflict, and (iii) enable a fair and effective justice system. Our products and technology
solutions address complex, high-stakes challenges, and our mission attracts top talent. We aim to invent and deliver
technology solutions that progressively make the right things easier and the wrong things harder every day.
Axon is a diversified technology company with employees distributed across multiple geographies. Alongside our primary
corporate headquarters in Scottsdale, Arizona, we have hubs in many major cities across the United States and ongoing
international expansion across Europe, Asia, and the Americas, as we continue to drive our mission globally.
Our Business Segments
As of January 1, 2025, we realigned our business to better reflect our continued growth and expansion of our technology
solutions. Previously reported within two reportable segments, TASER and Software and Sensors, we realigned our
business in a manner that provides increased transparency and distinction between our software and services and hardware
components. Axon’s operations comprise a fully integrated suite of products across connected hardware, software, and
services which are disclosed in two reportable segments:
Software and Services: We develop, manufacture and sell cloud-based Software-as-a-Service solutions that
leverage AI and enable our customers to capture, securely store, manage, share and analyze video and other digital
evidence. Our software offerings also support productivity and real-time operations.
Connected Devices: We develop, manufacture and sell fully integrated hardware solutions, such as conducted
energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone
technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
Table of Contents
Key Performance Highlights (1)
Annual revenue increased over 33% to mark our fourth consecutive year of 30%+ annual growth
Annual net income of $125 million supported adjusted EBITDA of $710 million
Generated annual bookings of $7.4 billion, up 46% year over year
Introduced major product expansions, including Axon Vehicle Intelligence, Axon Assistant, Axon Body Mini and
Axon 911
Revenue
Total company revenue of $2.8 billion in 2025 achieved through compound annual revenue growth of 33% from 2022.
1306
1307
1308
Profitability Measures
We delivered a full-year net income margin of 4.5% alongside a 25.5% adjusted EBITDA margin reflecting approximately
600 basis points of expansion since 2022.
1475
1476
1477
Total Shareholder Returns (2)
AXON ranks above the 93rd percentile among all S&P 500 companies for shareholder three-, five- and 10-year returns.
1634
1635
1636
(1)Adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures; see “Reconciliation of Non-GAAP
Measures” for definitions of non-GAAP financial measures and a reconciliation of such measures to the most directly
comparable GAAP measures.
(2)Represents stock price performance through December 31, 2025.
Table of Contents
CORPORATE GOVERNANCE HIGHLIGHTS
Board
Governance Oversight
Shareholder Rights & Engagement
Independent board leadership
Majority independent board
Directors with a wide range of
skills, expertise and multi-faceted
backgrounds
Regular board refreshment—four
new directors added since 2023
Average director age: 58
Average director tenure: 10 years
One share, one vote equity structure
Annual director elections
Majority vote standard
Public board service limits
Director tenure and term limits
Ability for shareholders to call a
special meeting
Ability for shareholders to act by
written consent
Regular shareholder engagement
with our investors to understand
their views and seek feedback
“Proxy access” bylaw provision
Governance Structures Unique to Axon’s Business
Standing Board Committees
Advisory Boards
Audit Committee
Compensation Committee
Nominating and Corporate Governance Committee,
including oversight of Environmental, Social and
Governance (“ESG”) and sustainability-related risks
Enterprise Risk and Compliance Committee, including
oversight of cybersecurity risk in consultation with our
Audit Committee
Mergers and Acquisitions and Capital Structure
Committee
Ethics & Equity Advisory Council (“EEAC”)
composed of community leaders and community-
focused academics, provides our Board with insight
into the responsible development and deployment of
new technology — including artificial intelligence —
in both public safety and community contexts. The
EEAC assists with gap analyses and helps us develop
toolkits, training, and product review processes to
support ethical product design
Scientific and Medical Advisory Board composed of
experts from several fields who help to ensure our
Board is aware of evolving technology, practices and
regulations material to our TASER devices so that the
Board can appropriately oversee Axon’s strategy
Table of Contents
Image New.jpg
AXON ENTERPRISE, INC.
17800 North 85th Street
Scottsdale, Arizona 85255
_____________________________________________________
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
May 28, 2026
_____________________________________________________
To Our Shareholders:
The 2026 Annual Meeting of Shareholders (the “Annual Meeting”) of Axon Enterprise, Inc. (the “Company” or “Axon”)
will be held at 1:00 p.m. Pacific time on Thursday, May 28, 2026. The Annual Meeting will be a completely virtual
meeting of shareholders. You will be able to attend the Annual Meeting, vote your shares electronically, and submit your
questions during the live webcast by visiting www.virtualshareholdermeeting.com/AXON2026. You will need to have
your 16-digit control number included on your Notice of Internet Availability of Proxy Materials, on your proxy card, or on
your voting instruction card or form or other instructions that accompanied your proxy statement. The Annual Meeting will
be held for the following purposes:
1.Election of the directors of the Company named in the proxy statement;
2.Advisory vote to approve the compensation of the Company’s named executive officers; and
3.Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public
accounting firm for fiscal year 2026.
Only shareholders of record of the Company’s common stock at the close of business on March 31, 2026 are entitled to
notice of, and to vote at, the Annual Meeting or any postponement or adjournment thereof. Only shareholders with a valid
16-digit control number will be able to attend the Annual Meeting and vote, ask questions, and access the list of
shareholders as of the close of business on the record date for the Annual Meeting.
Your vote is very important. Whether or not you plan to attend the Annual Meeting, we encourage you to read the
proxy statement and vote as soon as possible. For specific instructions on how to vote your shares, please refer to the
section entitled “General Information About the Annual Meeting and Voting” in the proxy statement and the
instructions on your proxy card or the voting instruction card or form you receive from your broker, bank or other
intermediary. Please note that, if you hold shares in different accounts, it is important that you vote the shares
represented by each account.
Table of Contents
If you have any questions concerning the proxy statement or the proposals, would like additional copies of the proxy
statement or need help voting your shares of Axon, please contact Axon’s proxy solicitor:
Innisfree M&A Incorporated
501 Madison Avenue
New York, NY 10022
Shareholders Call Toll Free: (877) 750-8129
International Callers: +1 (412) 232-3651
Brokers and Banks Call: (212) 750-5833
By Order of the Board of Directors,
/s/ ISAIAH FIELDS
Isaiah Fields
Corporate Secretary
Scottsdale, Arizona
April 16, 2026
YOUR VOTE IS IMPORTANT. WHETHER OR NOT YOU EXPECT TO ATTEND THE ANNUAL MEETING,
PLEASE VOTE ON THE INTERNET, BY TELEPHONE, OR MARK, SIGN, DATE AND PROMPTLY RETURN
YOUR PROXY OR VOTING INSTRUCTION CARD OR FORM IN THE ENCLOSED ENVELOPE.
Table of Contents
TABLE OF CONTENTS
General Information About the Annual Meeting and Voting
1
Governance
6
The Board of Directors
6
Board and Committee Governance
18
Director Compensation
25
Certain Relationships and Related Party Transactions
28
Share Ownership
29
Ownership of Equity Securities of the Company
29
Executive Compensation
31
Executive Officers
31
Compensation Discussion and Analysis
34
Summary Compensation Table
47
Grants of Plan-Based Awards
48
Outstanding Equity Awards at Year-End
49
Option Exercises and Stock Vested
50
Nonqualified Deferred Compensation
51
Potential Payments upon Termination or Change of Control
52
Pay versus Performance
55
Pay Ratio of CEO Compensation to Median Employee Compensation
59
Audit Matters
60
Report of the Audit Committee
60
Proposals
62
Proposal No. 1 – Election of Directors
63
Proposal No. 2 – Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers
64
Proposal No. 3 – Ratification of Appointment of Independent Registered Public Accounting Firm
66
Other Matters
68
Reconciliation of Non-GAAP Measures
70
Axon Enterprise, Inc. | 2026 Proxy Statement | 1
Table of Contents
Image New.jpg
AXON ENTERPRISE, INC.
17800 North 85th Street
Scottsdale, Arizona 85255
_________________________________________________________
PROXY STATEMENT FOR 2026 ANNUAL MEETING OF SHAREHOLDERS
_________________________________________________________
GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING
Why am I receiving these proxy materials?
The Board of Directors (the “Board” or “Board of Directors”) of Axon Enterprise, Inc. (the “Company” or “Axon”) has
made these proxy materials available to you on the Internet or has delivered printed copies of these proxy materials to you
by mail in connection with the Board of Directors’ solicitation of proxies for use at the 2026 Annual Meeting of
Shareholders (the “Annual Meeting”), which will take place virtually at 1:00 p.m. Pacific time on Thursday, May 28, 2026.
You will be able to attend the Annual Meeting, vote your shares electronically, access the list of shareholders as of the
close of business on March 31, 2026 (the “Record Date”), and submit your questions during the live webcast by visiting
www.virtualshareholdermeeting.com/AXON2026. You will need to have your 16-digit control number included on your
Notice of Internet Availability of Proxy Materials (the “Notice”), on your proxy card, or on your voting instruction card or
form or other instructions that accompanied your proxy statement (“Voting Instruction Card”). We recommend logging
into the Annual Meeting prior to the start time. This proxy statement describes the matters on which you, as a shareholder,
are entitled to vote. It also gives you information on these matters so that you can make an informed decision. This proxy
statement is first being made available or sent to shareholders on or about April 16, 2026.
What is included in these materials?
These materials include:
¨
This proxy statement for the Annual Meeting; and
¨
The Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Annual
Report”).
If you received printed copies of the proxy materials by mail, the proxy materials also include the proxy card or Voting
Instruction Card for the Annual Meeting.
Why did I receive a one-page notice in the mail regarding the Internet availability of these proxy materials instead of a
printed copy of these proxy materials?
In accordance with the rules of the Securities and Exchange Commission (the “SEC”), instead of mailing printed copies of
the proxy materials to all of our shareholders, we have elected to furnish such materials to shareholders by providing access
to these documents over the Internet. Accordingly, on April 16, 2026, we sent the Notice to shareholders of record and
beneficial owners of shares of our common stock as of the Record Date. Shareholders have the ability to access the proxy
materials on a website referred to in the Notice or request to receive a printed or electronic copy of the proxy materials by
following the directions found in the Notice. The Company encourages you to take advantage of the availability of the
proxy materials on the Internet in order to help reduce the cost and environmental impact of the Annual Meeting.
Axon Enterprise, Inc. | 2026 Proxy Statement | 2
Table of Contents
How can I get electronic access to the proxy materials?
The Notice provides you with instructions regarding how to: (1) view our proxy materials for the Annual Meeting on the
Internet; (2) vote your shares after you have viewed our proxy materials; (3) request a printed or electronic copy of the
proxy materials; and (4) instruct us to send our future proxy materials to you electronically via email. Copies of the proxy
materials are also available for viewing on the investor relations page of the Company’s website at http://
investor.axon.com.
What proposals will be voted on at the Annual Meeting and how does the Board of Directors recommend I vote?
Shareholders will vote on the following items at the Annual Meeting:
Proposal
Description
Board Recommendation
No. 1
Election of the directors of the Company named in this proxy statement
FOR
(all nominees)
No. 2
Advisory vote to approve the compensation of the Company’s named
executive officers
FOR
No. 3
Ratification of the appointment of PricewaterhouseCoopers LLP as the
Company’s independent registered public accounting firm for fiscal year
2026
FOR
Shareholders will also vote on the transaction of any other business as may properly come before the Annual Meeting or
any postponement or adjournment thereof. To the maximum extent allowed by the SEC’s proxy rules, the proxy holders
will vote your shares on such other matters as they determine in their discretion.
Where are the Company’s principal executive offices located and what is the Company’s main telephone number?
The Company’s principal executive offices are located at 17800 North 85th Street, Scottsdale, Arizona 85255. The
Company’s main telephone number is (480) 991-0797.
Who may vote at the Annual Meeting?
As of the Record Date, there were 80,572,201 shares of the Company’s common stock outstanding. Each share of common
stock entitles the holder to one vote on each matter that may properly come before the Annual Meeting or any
postponement or adjournment thereof. The holders of a majority of the voting power of all shares entitled to vote, present
in person (virtually) or represented by proxy, will constitute a quorum for the transaction of business at the Annual
Meeting. Shareholders are not entitled to cumulative voting in the election of directors. Only shareholders as of the close of
business on the Record Date are entitled to receive notice of, to attend, and to vote at the Annual Meeting.
What is the difference between a shareholder of record and a beneficial owner of shares held in street name?
Shareholder of Record
If your shares are registered directly in your name with the Company’s transfer agent, Broadridge Corporate Issuer
Solutions, Inc., you are considered the shareholder of record with respect to those shares, and the Notice or printed copies
of the proxy materials were sent directly to you by the Company. If you request printed copies of the proxy materials by
mail, you will also receive a printed proxy card.
Beneficial Owner of Shares Held in Street Name
If your shares are held in an account at a broker, bank or other intermediary, then you are the beneficial owner of shares
held in “street name,” and the Notice or printed copies of the proxy materials were forwarded to you by that organization.
The organization holding your account is considered the shareholder of record for purposes of voting at the Annual
Meeting. As a beneficial owner, you have the right to direct that organization how to vote the shares held in your account.
If you request printed copies of the proxy materials by mail, you will also receive a printed Voting Instruction Card.
Axon Enterprise, Inc. | 2026 Proxy Statement | 3
Table of Contents
If I am a shareholder of record of the Company’s shares, how do I vote?
There are multiple ways to vote:
:         Via the Internet. If you received a Notice, you may vote via the Internet:
Before the Meeting: until 11:59 p.m. Eastern time on May 27, 2026, visit www.proxyvote.com and enter
the control number found in the Notice.
During the Meeting: visit www.virtualshareholdermeeting.com/AXON2026 and enter the control
number found in the Notice.
(       By telephone. If you received or requested printed copies of the proxy materials by mail, until 11:59 p.m.
Eastern time on May 27, 2026, you may vote by calling the toll-free number found on the proxy card.
By mail. If you received or requested printed copies of the proxy materials by mail, you may vote by
filling out the proxy card and returning it in the envelope provided.
If I am a beneficial owner of shares held in street name, how do I vote?
Your broker or bank will send you instructions on how to vote. There are multiple ways to vote:
:           Via the Internet. If you received a Notice, you may vote via the Internet:
Before the Meeting: until 11:59 p.m. Eastern time on May 27, 2026, visit www.proxyvote.com and enter
the control number found in the Notice.
During the Meeting: visit www.virtualshareholdermeeting.com/AXON2026 and enter the control number
found in the Notice.
(         By telephone. If you received or requested printed copies of the proxy materials by mail, until 11:59 p.m.
Eastern time on May 27, 2026, you may vote by calling the toll-free number found on the Voting Instruction Card.
,       By mail. If you received or requested printed copies of the proxy materials by mail, you may vote by
filling out the Voting Instruction Card and returning it in the envelope provided.
To attend and participate in the Annual Meeting, you will need the 16-digit control number included on your Notice, on
your proxy card or on your Voting Instruction Card. If your shares are held in street name, you should contact your broker
or bank to obtain your 16-digit control number or otherwise vote through your broker or bank. Only shareholders with a
valid 16-digit control number will be able to attend the Annual Meeting and vote, ask questions and access the list of
shareholders as of the close of business on the Record Date for the Annual Meeting.
What constitutes a quorum in order to hold and transact business at the Annual Meeting?
Under Delaware law and the Company’s Bylaws (as amended and restated, the “Bylaws”), the holders of a majority of the
voting power of all shares entitled to vote, present in person or represented by proxy, at a meeting constitutes a quorum.
Abstentions and broker non-votes will be counted as present to determine whether a quorum has been established. Once a
share of the Company’s common stock is represented for any purpose at a meeting, it is deemed present for quorum
purposes for the remainder of the meeting and any adjournment thereof. If a quorum is not present, the Annual Meeting
may be postponed or adjourned until a quorum is obtained.
How are proxies voted?
All valid proxies received prior to the Annual Meeting will be voted. All shares represented by a proxy will be voted and,
where a shareholder specifies by means of the proxy a choice with respect to any matter to be acted upon, the shares will be
voted in accordance with the shareholder’s instructions.
Axon Enterprise, Inc. | 2026 Proxy Statement | 4
Table of Contents
What happens if I do not give specific voting instructions?
Shareholder of Record
If you are a shareholder of record and you indicate when voting on the Internet or by telephone that you wish to vote as
recommended by the Board, or sign and return a proxy card without giving specific voting instructions, then the proxy
holders will vote your shares in the manner recommended by the Board on all matters presented in this proxy statement and
as the proxy holders may determine in their discretion with respect to any other matters properly presented for a vote at the
Annual Meeting.
Beneficial Owner of Shares Held in Street Name
If you are a beneficial owner of shares held in street name and do not provide the organization that holds your shares with
specific voting instructions, the organization that holds your shares may vote on routine matters but cannot vote on non-
routine matters. If the organization that holds your shares does not receive instructions from you on how to vote your
shares on a non-routine matter, the organization that holds your shares will inform the inspector of election that it does not
have the authority to vote on such matters with respect to your shares. This is generally referred to as a “broker non-vote.”
Which ballot measures are considered “routine” or “non-routine”?
Proposals No. 1 and No. 2 (election of the directors, and the advisory vote to approve the compensation of the Company’s
named executive officers) are considered “non-routine.” A broker or other nominee cannot vote without specific voting
instructions from the beneficial owner on non-routine matters, and therefore we anticipate there will be broker non-votes in
connection with Proposals No. 1 and No. 2.
Proposal No. 3 (ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered
public accounting firm for fiscal year 2026) is considered “routine.” A broker or other nominee may generally vote on
routine matters, and therefore no broker non-votes are expected in connection with this proposal.
Can I change my vote after I have voted?
You may revoke your proxy and change your vote at any time before the final vote during the Annual Meeting, subject to
the instructions provided on your Notice, on your proxy card or on your Voting Instruction Card, by voting again via the
Internet or by telephone (only your latest Internet or telephone proxy submitted prior to the final vote during the Annual
Meeting will be counted), by signing and returning a new proxy card or Voting Instruction Card with a later date that is
received prior to the Annual Meeting, or by attending the Annual Meeting and voting during the meeting. However, your
attendance at the Annual Meeting will not automatically revoke your proxy unless you vote again during the Annual
Meeting or specifically request that your prior proxy be revoked by delivering to the Company’s Corporate Secretary at
17800 North 85th Street, Scottsdale, Arizona 85255 a written notice of revocation and is received prior to the Annual
Meeting.
Is my vote confidential?
Proxy instructions, ballots and voting tabulations that identify individual shareholders are handled in a manner that protects
your voting privacy. Your vote will not be disclosed either within the Company or to third parties, except as necessary to
meet applicable legal requirements, to allow for the tabulation and certification of votes, and to facilitate a successful proxy
solicitation.
What is the voting requirement to approve each of the proposals?
Election of Directors
For Proposal No. 1, under our Bylaws, assuming the existence of a quorum at the Annual Meeting, each director will be
elected by the affirmative vote of a majority of the votes properly cast for and against such nominee’s election. Abstentions
and broker non-votes will have no impact on the outcome of this proposal if a quorum is present.
Axon Enterprise, Inc. | 2026 Proxy Statement | 5
Table of Contents
Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers
For Proposal No. 2, assuming the existence of a quorum at the Annual Meeting, the affirmative vote of a majority of the
total votes properly cast for or against the proposal in person or by proxy at the Annual Meeting is required for approval,
on an advisory basis. Abstentions and broker non-votes will have no impact on the outcome of this proposal if a quorum is
present.
Ratification of Independent Registered Public Accounting Firm
For Proposal No. 3, assuming the existence of a quorum at the Annual Meeting, the affirmative vote of a majority of the
total votes properly cast for or against the proposal in person or by proxy at the Annual Meeting is required for ratification.
Abstentions will have no impact on the outcome of this proposal if a quorum is present.
Who will serve as the inspector of election?
A member of the Company’s internal legal department will serve as the inspector of election.
Where can I find the voting results of the Annual Meeting?
The final voting results will be tallied by the inspector of election and, within four business days after the Annual Meeting,
the Company expects to report the final results on Form 8-K filed with the SEC.
Who is paying for the cost of this proxy solicitation?
The Company will bear the cost of solicitation of proxies for the Annual Meeting. We are soliciting your proxy on behalf
of our Board. In addition to the use of mail, proxies may be solicited by personal interview, telephone, facsimile,
electronically, including email, or otherwise, by our directors, officers and other employees. They will not receive any
additional compensation for these activities. We have engaged Innisfree M&A Incorporated to assist in the solicitation of
proxies for a fee of $30,000 for services not yet contracted, plus reimbursement of reasonable expenses, and we have
agreed to indemnify Innisfree M&A Incorporated against certain losses, costs and expenses. We also will request persons,
firms and corporations holding shares in their names, or in the names of their nominees, that are beneficially owned by
others to send or cause to be sent proxy materials to, and obtain proxies from, such beneficial owners and will reimburse
such holders for their reasonable expenses in doing so.
Who can help answer my other questions?
If after reading this proxy statement you have more questions about the Annual Meeting or the proposals, you should
contact Innisfree M&A incorporated, our proxy solicitor, at:
Innisfree M&A Incorporated
501 Madison Avenue
New York, NY 10022
Shareholders Call Toll Free: (877) 750-8129
International Callers: +1 (412) 232-3651
Brokers and Banks Call: (212) 750-5833
Axon Enterprise, Inc. | 2026 Proxy Statement | 6
Table of Contents
GOVERNANCE
THE BOARD OF DIRECTORS
Role of the Board of Directors
The principal duties of the Board of Directors are to provide independent oversight of management and the Company's
strategic direction. The fundamental responsibility of the directors is to exercise their business judgment to act in what they
reasonably believe to be the best interest of the Company and its shareholders. The Board also oversees risk management
and succession planning, and upholds the integrity of the Company's financial reporting, disclosures, and compliance
programs. Our governance framework is designed to promote accountability, informed decision-making, and effective
oversight of strategy, performance, and risk.
Axon’s key governance documents, including our Corporate Governance Guidelines, are available at https://
investor.axon.com/Governance-Documents.
Director Nominations
Our Nominating and Corporate Governance Committee (the “NCG Committee”) is responsible for identifying, evaluating,
and recommending qualified director candidates to the Board for nomination and election at each annual meeting of
shareholders, with a focus on skills, experience, and expertise best suited to oversee the Company's strategy and operations.
The NCG Committee may consider candidates recommended by directors, management, or shareholders, and, at times,
may retain third-party search firms to assist in the identification and evaluation of candidates.
Shareholders who wish the NCG Committee to consider their recommendations for nominees for the position of director
should submit their recommendations in writing by mail to the NCG Committee, c/o Axon Enterprise, Inc., 17800 North
85th Street, Scottsdale, AZ 85255, in accordance with the procedures in our Bylaws. Recommendations by shareholders
that are made in accordance with these procedures will receive the same consideration by the NCG Committee as other
suggested nominees.
Qualifications for All Directors
In its assessment of each potential director nominee, including those recommended by shareholders, the NCG Committee
considers the potential nominee’s demonstrated skills, expertise, character, judgment, relevant functional and industry
experience, and whether they possess a high degree of business, financial, governmental, military and/or law enforcement,
technological, cybersecurity, risk oversight, corporate governance or human capital management acumen, independence,
and other factors the NCG Committee determines are pertinent in light of the current needs of the Board. The NCG
Committee also takes into account the ability of a potential director nominee to devote the time and effort necessary to
fulfill his or her responsibilities to the Board of Directors. The NCG Committee engages in regular succession planning for
the Board and key leadership roles on the Board. As part of this succession planning process, the NCG Committee
considers the experiential diversity and tenure of the current directors and the mix of backgrounds on the Board. While the
NCG Committee does not have a formal diversity policy, the Board believes that the Company benefits from a well-
rounded balance of varying qualifications, attributes, skills and experience in the composition of the Board.
The NCG Committee engages in ongoing succession planning for the Board and key Board leadership roles. In doing so,
the NCG Committee regularly reviews the Board’s composition in light of the skills, experience and other attributes that
will best position the Board to oversee the Company’s strategy and governance needs over time. This review is informed
by the Board’s self-evaluation process, anticipated Board transitions, and the Committee’s view of the qualifications and
experience most valuable in future director nominees. While the NCG Committee does not have a formal diversity policy,
the Board believes that the Company benefits from a well-rounded balance of varying qualifications, attributes, skills and
experience in the composition of the Board.
Axon Enterprise, Inc. | 2026 Proxy Statement | 7
Table of Contents
The NCG Committee’s process for identifying and evaluating director nominees is ongoing and typically involves
discussions among Committee members, review of information concerning potential candidates, interviews with selected
candidates, and, from time to time, engagement of third-party firms to assist in identifying, screening or evaluating
potential nominees.
Majority Voting Standard and Resignation Policy
Our Bylaws provide that we use a majority voting standard instead of a plurality voting standard in uncontested elections.
Under this standard, an uncontested director must receive a majority of the votes properly cast for and against such
nominee and, if they do not, they must tender their resignation for Board consideration. For contested elections where the
number of director nominees exceeds the number of Board seats open for election, each person nominated to be elected as
a director is elected by a plurality of the votes properly cast.
If an incumbent director receives less than a majority of the votes cast with respect to such director’s election in an
uncontested election, such director will promptly tender his or her resignation to the NCG Committee. No later than 90
days following the receipt of any such tendered resignation, (i) the Board will, taking into account any recommendation by
the NCG Committee, take formal action with respect thereto (which action may include accepting or rejecting such
tendered resignation, or taking other action considered appropriate) and (ii) the Company will publicly disclose the Board’s
decision and, in the event that the Board of Directors does not accept any such tendered resignation, the rationale for such
decision. The director who tenders his or her resignation will not participate in the recommendation of the NCG Committee
or the decision of the Board with respect to his or her resignation. The NCG Committee, in making any recommendation,
and the Board, in making any decision, may consider any factors or other information they consider appropriate or relevant.
If the Board accepts a tendered resignation, then the Board may fill the resulting vacancy or may decrease the size of the
Board.
Shareholder Engagement
The Board of Directors values ongoing dialogue with Axon’s shareholders and maintains a regular engagement program to
solicit feedback on key matters. Management, led by the Investor Relations team, engages regularly with investors and
analysts on strategy, financial and operating performance, and responds to inbound inquiries. Axon also conducts targeted
outreach on corporate governance topics, including executive compensation and governance practices, with appropriate
members of management, and, at times, members of the Board.
Feedback from these engagements is shared with the Board and helps inform its oversight of topics, such as executive
compensation, strategic priorities, disclosures, and Board composition. Axon also engages with shareholders in advance of
its annual meeting, as appropriate, to discuss matters subject to shareholder vote. These meetings strengthen Axon’s
relationships with our shareholders and reinforce our commitment to be responsive to their feedback.
Seeking feedback on our 2024 say-on-pay vote, we launched an expanded shareholder outreach initiative last year. Our
goal was to better understand shareholder concerns and gather input on desired changes to our executive compensation
program. Throughout 2025, we continued engaging with shareholders on executive compensation, corporate governance,
strategy, and Board composition. We solicited feedback from over 30 shareholders, representing greater than 40% of our
outstanding shares. These engagements were led by our Head of Investor Relations and included a Board member from the
Compensation Committee, as appropriate.
Axon Enterprise, Inc. | 2026 Proxy Statement | 8
Table of Contents
2025 Shareholder Engagement Outreach Efforts
Number of shareholders
contacted:
Percent of Outstanding
Shares Contacted:
Percent of Outstanding
Shares Engaged:
>30
~60%
>40%
Board Governance Enhancements as a Result of Shareholder Feedback
Our Board strives to continually enhance our governance structures and adopt industry and market best practices.
Engagement with our shareholders and feedback from those conversations help to inform the Board’s decision-making in
implementing policies, practices and governance structures in line with investor expectations and those that enable
effective risk oversight at the Board level. Consistent with this approach, the Board has implemented the following policies
and Bylaw amendments in recent years as a result of shareholder feedback:
establishing a Human Rights Policy that extends to our employees, officers, directors, partners, vendors, and
suppliers worldwide and is based on our goal of upholding the highest standards;
refreshing our Board's tenure and term limits;
enhancing our Political Contributions Policy and disclosures; and
review of executive compensation structures, which are designed to retain and incentivize key talent for sustained
long-term shareholder value creation
Human Rights Policy
The Board formalized our Human Rights Policy to align with international standards, including the United Nations Guiding
Principles on Business and Human Rights. The policy reinforces Axon’s commitment to fair labor practices, non-
discrimination and ethical supply chain standards, including the prohibition of forced labor, human trafficking and child
labor. It also affirms the Company’s support for equal employment opportunities, freedom of association, and a diverse and
inclusive workplace. To strengthen compliance, Axon has established clear reporting mechanisms to address human rights
concerns and ensure accountability across our operations and supply chain. This policy reflects Axon’s dedication to
responsible business conduct and our mission to protect life with integrity and respect for human dignity.
Board Refreshment, Tenure, and Term Limits
The Board values the views and contributions of directors who bring newer perspectives, as well as those who offer deep
institutional knowledge of the Company’s business, governance, and strategy, developed over time. As part of the Board’s
ongoing refreshment efforts, four new directors have been added to the Board since 2023. In addition, as part of the process
to help facilitate a smooth transition of new directors that have been added since that time, and as previously announced in
8-K filings earlier this year, directors Julie Cullivan and Matthew McBrady will not stand for re-election and will serve
until their terms expire at the 2026 annual meeting. Both Ms. Cullivan and Mr. McBrady have shown deep commitment,
leadership, and contribution to the Board during their multi-year tenures.
To further our commitment to ensuring meaningful Board refreshment, the Company’s Corporate Governance Guidelines
implement a formal term limit (as defined below) for directors in order to ensure alignment of director qualifications,
attributes, skills, and experience with the Company’s evolving strategy. Each non-executive director of the Company must
submit a letter of resignation to the Chair of the NCG Committee upon reaching 20 continuous years of service as a
director of the Company or age 75 (the “term limit”), whichever occurs first, and each year thereafter, which letter of
resignation may be accepted or rejected by the Board in its sole discretion. Prior to August 2024, the term limit was the
earlier of 20 continuous years of service as a director of the Company or age 72 (the “prior term limit”).
Pursuant to the prior term limit, on February 27, 2024, Mr. Garnreiter provided his letter of resignation to the Chair of the
NCG Committee. After considering Mr. Garnreiter’s leadership roles as Chair of the Board and Audit Committee Chair,
particularly in light of the Company’s recent transition in independent registered public accounting firms, the NCG
Committee recommended to the Board that it decline Mr. Garnreiter’s offer to resign to provide additional time to plan for
his succession. On March 4, 2024, the Board determined to follow the NCG Committee’s recommendation, declined Mr.
Garnreiter’s offer to resign, and appointed Mr. Graham Smith as Audit Committee Chair to provide for a smooth future
transition. Pursuant to the revised term limit Mr. Garnreiter was not required to submit a letter of resignation in 2025.
Axon Enterprise, Inc. | 2026 Proxy Statement | 9
Table of Contents
Political Contributions Disclosures and Policy
Axon participates in the public policy process on issues relevant to its business, mission, and shareholders, in compliance
with applicable laws and regulations. The Board of Directors, through its Nominating and Corporate Governance
Committee, oversees Axon’s political spending activities. Axon has committed to provide annual updates regarding its
political contributions and related policies and practices. Any political contributions made with corporate funds are subject
to applicable law and require prior approval in accordance with Company policy and internal controls.
Other Governance Features
Our Board has previously adopted other policies, practices and governance structures that we believe are in line with
investor expectations, aligned with industry and market best practices and enable effective risk oversight at the Board level.
Director Commitments and Service on Other Boards
The Board of Directors recognizes the time commitment that service on a board of directors requires, as well as other
commitments applicable to the Company’s directors. The Company’s Corporate Governance Guidelines establish limits on
the number of boards on which our directors may serve. A director who is not a named executive officer of a public
company may serve on a total of four public company boards, including the Company’s Board. A director who is also a
named executive officer of a public company may serve on a total of two public company boards, including the Company’s
Board.
Proxy Access
Our Bylaws include a “proxy access” provision, which permits a shareholder, or a group of up to 20 shareholders, who own
3% or more of our voting stock continuously for at least three years, to nominate and include in our annual meeting proxy
materials director nominees constituting up to the greater of two directors or 20% of the Board, subject to certain
conditions and provided that the shareholder(s) and director nominee(s) satisfy all eligibility, procedural and disclosure
requirements specified in our Bylaws, including that each director nominee submitted through the proxy access provisions
must meet the qualifications to be an independent director.
Exclusive Forum
Our Bylaws provide as an exclusive forum (i) the Delaware Court of Chancery for certain types of actions and claims
(including derivative actions, actions asserting a claim of breach of fiduciary duty and actions against us arising pursuant to
the Delaware General Corporation Law or our organizational documents) and (ii) the federal district courts of the United
States for claims arising under the Securities Act of 1933, as amended (the “Securities Act”), in each case subject to certain
limitations. Our Board believes this provision is in the best interest of Axon and its shareholders. First, designating a forum
in which certain claims can be brought promotes the efficient resolution of such claims and reduces the likelihood of
duplicative lawsuits being brought in multiple jurisdictions. Further, the ability of plaintiffs to litigate claims governed by
Delaware law in courts other than the Delaware Court of Chancery may mean that claims are brought in courts that may
not apply Delaware law in the same manner as the Delaware Court of Chancery. The Delaware Court of Chancery’s
considerable expertise has led to the development of a substantial and influential body of case law interpreting Delaware
corporate law. We expect this will provide us and our shareholders with more consistency and predictability regarding the
outcome of corporate disputes, which can minimize the time, cost and uncertainty of litigation for all parties. Similarly, the
Board believes designating the federal district courts of the United States as the exclusive forum for claims brought under
the Securities Act prevents forum shopping of state courts by plaintiffs and facilitates review of Securities Act claims by
judges in federal courts that may have significant experience and expertise in adjudicating such claims. The exclusive
forum provision in our Bylaws does not apply to suits brought to enforce any liability, obligation or duty created by the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) to the extent such application would be contrary to
law.
Axon Enterprise, Inc. | 2026 Proxy Statement | 10
Table of Contents
Our Highly Qualified Board of Directors
The Board has identified particular qualifications, attributes, skills, expertise and experience that it believes are important
to be represented on the Board as a whole in order to advise and contribute to the execution of the Company’s strategic
objectives. Each Board member was selected in accordance with the process for identifying and evaluating director
nominees described above. Accordingly, the Board believes that each of the Company’s Board members brings a myriad of
qualifications, attributes, skills , expertise and experience that are a combined benefit to the Company and its shareholders.
While recognizing that any group of people is more than the sum of its parts, that biography does not always define identity
and that attempting to quantify diversity is an imperfect exercise in a world of unique individuals, we also acknowledge
and celebrate that our Board intentionally reflects a wide range of human experiences and identities.
Board Demographics
Our Board represents a range of highly relevant skills and experiences, coupled with diverse educations and backgrounds,
that enhance the Board’s collective perspective and decision-making, while providing for effective oversight of the
Company. The demographic information provided below is based on voluntary self-identification by each director
nominee.
13702
13703
27% Racially
Diverse
45% Women
Board Skills Matrix
Skills and Experience
Ayers
Brown
Cullivan
Garnreiter
Kalinowski
McBrady
Morgenfeld
Partovi
G. Smith
P. Smith
Williams
Total
CEO/senior executive
experience
11
Accounting/auditing
experience
3
Governmental,
regulatory and/or legal
experience
2
Military and/or law
enforcement experience
2
Technology expertise
7
Risk oversight and
management
9
Public company board
experience/corporate
governance
6
Human capital
management
1
Director since
2023
2020
2017
2006
2019
2016
2025
2010
2023
1993
2023
Axon Enterprise, Inc. | 2026 Proxy Statement | 11
Table of Contents
Directors and Director Nominees in 2026
Erika Ayers.jpg
Erika Ayers Badan
Director since 2023
Age: 50
Board Committee: Compensation Committee, Nominating and Corporate Governance Committee
Other Public Companies Boards: None
Ms. Ayers Badan was Chief Executive Officer (“CEO”) of Food52 from April 2024 to February 2026 when it was sold to
America’s Test Kitchen. Ms. Ayers Badan was previously CEO of Barstool Sports from 2016 through January 2024,
during which time it experienced tremendous brand and business growth as one of the fastest-growing digital innovation,
sports, entertainment and lifestyle media brands on the Internet. Prior to joining Barstool Sports, Ms. Ayers Badan held
various executive roles at media platforms such as Microsoft Corporation, AOL, Leaf Group (formerly Demand Media,
Inc.) and Yahoo! Inc. She has extensive experience in transforming start-up organizations into multi-industry operations.
She was also part of two early stage start-ups in the fashion and music industry and sits on the advisory board of both
Vice Media Group and the Premier Lacrosse League. Ms. Ayers Badan previously served on the board of directors of
World Wrestling Entertainment, Inc. from October 2020 to September 2022. Ms. Ayers Badan holds a B.S. in Sociology
from Colby College.
Specific Qualifications, Attributes, Skills and Experience:
Technology Expertise
Experience as an executive of media platform companies provides Ms.
Ayers with valuable insight into communication expertise, Internet-related
business development demands and brand building.
Risk Oversight & Management; Public
Company Board Experience/Corporate
Governance
Experience as an advisor to multiple companies and as a board member of
World Wrestling Entertainment, Inc. from October 2020 to September
2022 provides insight into public company corporate governance matters.
Sullivan_20230317_Brown_Adriane__5390.jpg
Adriane Brown
Director since 2020
Age: 67
Board Committees: Compensation Committee, Nominating and Corporate Governance Committee
(Chair), Enterprise Risk and Compliance Committee
Other Public Company Boards: American Airlines Group Inc., eBay Inc., KKR & Co Inc.
Ms. Brown has been a Managing Director at Flying Fish Partners, a technology focused venture capital firm, since 2020
and joined as a Venture Partner in 2018. Prior to that, Ms. Brown served as President and Chief Operating Officer for
Intellectual Ventures (“IV”), an invention and investment company that commercializes inventions, from January 2010
through July 2017, and served as a Senior Advisor until December 2018. Before joining IV, Ms. Brown served as
President and CEO of Honeywell Transportation Systems (“Honeywell”) from January 2005 to June 2009. Over the
course of 10 years at Honeywell, she held leadership positions serving the aerospace and automotive markets globally.
Prior to Honeywell, Ms. Brown spent 19 years at Corning, Inc., ultimately serving as Vice President and General
Manager, Environmental Products Division, having started her career there as a shift supervisor. Ms. Brown serves on the
boards of directors of American Airlines Group Inc., eBay Inc. and KKR & Co Inc. Ms. Brown also serves on the board
of directors of the International Women’s Forum. Previously, she served on the boards of directors of Allergan plc and
Raytheon Company until 2020, respectively, and Harman International Industries until 2017. Ms. Brown holds an
Honorary Doctorate of Humane Letters and a B.A. in environmental health from Old Dominion University and is a
winner of its Distinguished Alumni Award. She also holds a M.A. in Management from the Massachusetts Institute of
Technology where she was a Sloan Fellow.
Axon Enterprise, Inc. | 2026 Proxy Statement | 12
Table of Contents
Specific Qualifications, Attributes, Skills and Experience:
Technology Expertise
Ms. Brown is a Managing Director and member of the Investment
Committee at Flying Fish Partners. The fund invests in and supports start-
ups utilizing artificial intelligence and machine learning to transform
processes in a variety of market verticals. Over the course of her career,
Ms. Brown has engaged in business and technology transformations
across a number of businesses and markets.
Risk Oversight & Management; Public
Company Board Experience/Corporate
Governance
Board experience from Allergan plc, American Airlines Group Inc., eBay
Inc., KKR & Co Inc., Harman International Industries and Raytheon
Company provides extensive insight into public company corporate
governance matters.
Julie Anne Cullivan.jpg
Julie Cullivan (1)
Director since 2017
Age: 60
Board Committees: Enterprise Risk and Compliance Committee, Nominating and Corporate
Governance Committee
Other Public Company Boards: HeartFlow, Inc.
Ms. Cullivan has been a Special Advisor at Brighton Park Capital, an entrepreneur inspired growth equity firm since
2020. Prior to that, Ms. Cullivan was the Chief Technology and People Officer at Forescout Technologies, Inc.
(“Forescout”), reporting to the CEO, where she was responsible for leading the company’s business model
transformation, information technology strategy, security risk and compliance program, customer production operations,
and human resources. She joined in July 2017 and helped Forescout scale from a private company with $160 million in
revenue, through its successful initial public offering, to a publicly traded company with revenues of $330 million and a
$1.5 billion valuation. In addition to focusing on scale, Ms. Cullivan led Forescout’s operational transformation from an
appliance and license software business to a cloud subscription business. Forescout was acquired by Advent International,
a private equity firm, in 2020 and Ms. Cullivan left in January 2021. Prior to Forescout, Ms. Cullivan was an Executive
Vice President of Business Operations and Chief Information Officer at FireEye Inc. and a Senior Vice President at
McAfee Corp. Additionally, Ms. Cullivan held executive roles at Autodesk, Inc., EMC Corporation and Oracle
Corporation. Ms. Cullivan has served on the boards of directors of HeartFlow, Inc. (NASDAQ: HTFL) since 2020,
OPSWAT since 2021 and Cobalt.io since 2022 and previously served on the boards of Astra Space Inc. (NASDAQ:
ASTR), Judy Security, and SADA Systems. Ms. Cullivan holds a B.S. in Finance from Santa Clara University.
(1) Ms. Cullivan is not standing for re-election to the Board upon expiration of her current term at the Annual Meeting.
Specific Qualifications, Attributes, Skills and Experience:
Technology Expertise;
Cybersecurity Experience; Human Capital
Management
Ms. Cullivan is a special advisor at Brighton Park Capital. The firm
invests in technology, security, and healthcare sectors. Throughout her
career, Ms. Cullivan has lead digital technology transformation strategies
and cybersecurity & compliance programs at multiple enterprise
technology companies including three cybersecurity technology firms. In
her prior role, Ms. Cullivan was Chief Technology and People Officer at
Forescout where she led talent acquisition, total rewards strategy, and
culture.
Risk Oversight & Management; Public
Company Board Experience/Corporate
Governance
Experience as Chief Technology and People Officer at Forescout, and
Executive Vice President of Business Operations and Chief Information
Officer at FireEye Inc., leading cross functional initiatives and
information security strategy in a high-growth environment, provides
experience in risk management.
Axon Enterprise, Inc. | 2026 Proxy Statement | 13
Table of Contents
Sullivan_20230317_Garnreiter_Mike_5257.jpg
Michael Garnreiter, Chair of the Board
Director since 2006
Age: 74
Board Committees: Audit Committee, Compensation Committee, Nominating and Corporate
Governance Committee
Other Public Company Boards: Knight-Swift Transportation Holdings Inc., Amtech Systems, Inc.
Mr. Garnreiter most recently served as Vice President of Finance and Treasurer of Shamrock Foods, a privately held
manufacturer and distributor of foods and food-related products. He retired from this position in December 2015. From
January 2010 until August 2012, Mr. Garnreiter was a managing director of Fenix Financial Forensics, a Phoenix-based
litigation and financial consulting firm. From August 2006 through December 2009, Mr. Garnreiter served as managing
member of Rising Sun Restaurant Group, LLC, a private restaurant operating company. From April 2002 through June
2006, Mr. Garnreiter was Executive Vice President, Treasurer and Chief Financial Officer of the Main Street Restaurant
Group. Mr. Garnreiter previously served with the international accounting firm, Arthur Andersen, from 1974 through
March 2002 with increasing levels of responsibility, culminating as a partner. Additionally, Mr. Garnreiter has served on
the board of Knight-Swift Transportation Holdings Inc. since 2003 and has also served on the board of Amtech Systems,
Inc. since 2007. Mr. Garnreiter holds a B.S. in Accounting from California State University at Long Beach and is a
Certified Public Accountant.
Specific Qualifications, Attributes, Skills and Experience:
Accounting/Auditing Experience
As a Certified Public Accountant and former partner at Arthur Andersen,
Mr. Garnreiter has served on the audit committee of each board of
directors on which he has served in the past and has extensive knowledge
of SEC rules and regulations.
Risk Oversight & Management; Public
Company Board Experience/Corporate
Governance
Board experience from Knight-Swift Transportation Holdings Inc. and
Amtech Systems, Inc. provides extensive insight into public company
corporate governance matters.
Sullivan_20230317_Kalinowski_Caitlin_5484.jpg
Caitlin Kalinowski
Director since 2019
Age: 45
Board Committees: Audit Committee and Enterprise Risk and Compliance Committee (Chair)
Other Public Company Boards: None
Alongside her role as a Director at the Institute of Contemporary Art in San Francisco, Ms. Kalinowski is a past and
present strategic advisor at numerous start-up companies. Ms. Kalinowski most recently served as a Member of Technical
Staff at OpenAI where she focused on AI and robotics (from November 2024 to March 2026). Previously, she was the
head of the AR Glasses Hardware team at Meta’s Reality Labs division (from March 2022 to July 2024) and, before that,
led the VR Hardware team, where she played a key role in the design and engineering of Oculus’ award-winning VR
devices (from February 2013 to March 2022). Before working at Meta, Ms. Kalinowski was a Product Design Engineer at
Apple (from October 2005 to January 2013) where she was a technical lead on the Mac Pro and MacBook Air products
and was part of the original unibody MacBook Pro team. Ms. Kalinowski is also on the strategic board of Lesbians Who
Tech & Allies, the largest LGBTQ technical organization in the world. She also advises startups working with physical
products, drawing on over 20 years of experience in high-tech hardware development. Ms. Kalinowski holds a B.S. in
Mechanical Engineering from Stanford University.
Axon Enterprise, Inc. | 2026 Proxy Statement | 14
Table of Contents
Specific Qualifications, Attributes, Skills and Experience:
Technology Expertise
Ms. Kalinowski has extensive experience in established technology organizations such
as OpenAI, Meta and Apple. Ms. Kalinowski led technical teams at Apple and Meta
and was a Member of Technical Staff at OpenAI focusing on AI and robotics. She has
tremendous insight into product design and engineering for technology focused
initiatives.
Risk Oversight &
Management
Background as an advisor to multiple start-up companies provides Ms. Kalinowski
experience in the unique challenges facing companies pursuing new ventures.
Sullivan_20230317_Mcbrady_Matt_5425.jpg
Matthew McBrady, Ph.D. (1)
Director since 2016
Age: 55
Board Committees: Enterprise Risk and Compliance Committee, Mergers and Acquisitions and
Capital Structure Committee (Chair)
Other Public Company Boards: None
Dr. McBrady was appointed Chief Financial Officer of GoBrands, Inc., the parent firm of the leading global quick
commerce company, Gopuff, in November 2025. Previously, he was a Professor of Practice in Finance at the Darden
Graduate School of Business Administration at the University of Virginia (the “Darden School”), where he taught classes
in Corporate Financial Strategy, Corporate Financing, and Impact and ESG Investing since August 2020. Prior to
returning to academia, Dr. McBrady spent more than a decade as a private equity and hedge fund investor, serving as
Senior Advisor and co-Chief Investment Officer of Callaway Capital (from January 2017 to December 2019), Managing
Director of Investments at the Cystic Fibrosis Foundation (from September 2017 to January 2019) and Managing Director
and Chief Investment Officer of the Multi-Strategy Hedge Funds at BlackRock, Inc. (from January 2014 through
September 2016). Prior to joining BlackRock, Dr. McBrady served as Managing Director and Head of Investment
Strategy and Risk Management at Silver Creek Capital Management, LLC (from January 2009 through January 2014),
and as a Senior Associate and Vice President in the North American Private Equity group at Bain Capital, LLC (from
January 2007 to January 2009).
Prior to becoming a professional investor, Dr. McBrady served as both a senior economic policy advisor and finance
professor. During his earlier career in academia, Dr. McBrady also served as a Professor of Finance at the Darden School
(from May 2003 through December 2006) as well as the Wharton School of Business at the University of Pennsylvania
(from September 2002 through May 2003). From August 1998 through January 2000, Dr. McBrady served as an
international economist with President Clinton’s Council of Economic Advisers and the U.S. Treasury Department. In
addition to his work in the private sector and academia, Dr. McBrady currently serves as an advisor to a number of impact
investing funds and as a Director and the Chairman of the Investment Committee for Global Partnerships, a non-profit
impact investor that has deployed more than $800 million in concessionary loans to improve the lives of people living at
the bottom of the pyramid in Central and South America and Africa. Dr. McBrady holds a B.A. in Economics from
Harvard University, a M.Sc. in International Economics from Oxford University (U.K.) where he was a Marshall Scholar,
and a Ph.D. in Business Economics from Harvard University. Dr. McBrady previously served as a director for the
Company from January 2001 through June 2014.
(1) Dr. McBrady is not standing for re-election to the Board upon expiration of his current term at the Annual Meeting.
Specific Qualifications, Attributes, Skills and Experience:
Governmental Experience
Service as a member of President Clinton’s Council of Economic Advisors
provides deep insight into government processes.
Risk Oversight & Management
Teaching positions at the Harvard Business School, the Wharton School of
Business and the Darden Graduate School of Business Administration provide
valuable financial knowledge and context. Service as Chief Investment Officer
for BlackRock and investment strategy and management positions for other
investment management firms provide experience in risk management.
Axon Enterprise, Inc. | 2026 Proxy Statement | 15
Table of Contents
todd-morgenfeld_bio_thumb.jpg
Todd Morgenfeld
Director since 2025
Age: 54
Board Committees: Audit Committee, Mergers and Acquisitions and Capital Structure Committee
Other Public Company Boards: AppLovin Corporation, Urban Outfitters, Inc.
Mr. Morgenfeld has served as a member of the boards of directors of AppLovin Corporation, a marketing platform for
mobile app developers, since 2023, and Urban Outfitters, Inc., a lifestyle retail company, since 2019. He previously
served as Chief Financial Officer and then as Chief Financial Officer and Head of Business Operations (CFO/COO) at
Pinterest, Inc., a visual discovery engine and social media platform, from 2016 to 2023. Prior to Pinterest, he was Vice
President of Finance at Twitter, Inc. (2015–2016) and Treasurer and Senior Vice President of Financial Analytics and
Corporate Development at Hewlett-Packard Company, a global technology products and services provider (2013–2015).
Earlier, he was an investment partner at Silver Lake Partners, a global private equity firm focused on technology (2004–
2013), an Associate at Goldman Sachs & Co. (2001–2004), and served as a Captain in the U.S. Army’s Armor branch
(1994–1999). Mr. Morgenfeld holds a B.S. from the United States Military Academy at West Point, where he graduated
first in his class, and earned an M.B.A. from Stanford University Graduate School of Business.
Specific Qualifications, Attributes, Skills and Experience:
Accounting/Auditing Experience
Experience as Chief Financial Officer of Pinterest, Inc. and in senior finance
leadership roles across global technology businesses provides Mr. Morgenfeld
with deep insight into financial management, capital allocation and public
company financial reporting.
Military Experience
Service as a Captain in the United States Army provides valuable leadership
experience and insight into strategic planning and operational execution.
Risk Oversight & Management;
Public Company Board Experience/
Corporate Governance
Board experience at AppLovin Corporation and Urban Outfitters, Inc. provides
extensive insight into public company corporate governance matters.
Hadi Partovi.jpg
Hadi Partovi
Director since 2010
Age: 53
Board Committees: Compensation Committee (Chair), Mergers and Acquisitions and Capital
Structure Committee
Other Public Company Boards: MNTN, Inc.
Mr. Partovi is the Chairman and co-founder of the non-profit education organization Code.org and has served as a director
on the board of MNTN, Inc., since 2023. Mr. Partovi is a past or present strategic advisor or early investor at numerous
technology companies, including Facebook, Dropbox, Uber, Airbnb, SpaceX and Zappos. From 2009 through 2010, Mr.
Partovi was Senior Vice President of Technology for MySpace (via acquisition) and, from 2006 through 2009, he was
President and co-founder of iLike, Inc., which was acquired by MySpace in 2009. From 2002 through 2005, Mr. Partovi
was General Manager, Microsoft MSN Entertainment and MSN.com and, from 1999 through 2001, he was Co-Founder
and Vice President of Product and Professional Services for Tellme Networks, Inc. From 1994 through 1999, he was
Program Manager for Microsoft Internet Explorer. Mr. Partovi holds a B.A. and a M.S. in Computer Science, summa cum
laude, from Harvard University.
Specific Qualifications, Attributes, Skills and Experience:
Technology Expertise
Experience as an executive, entrepreneur, investor and advisor across a variety of
successful technology companies provides Mr. Partovi with invaluable insight
into software and Internet-related business development initiatives.
Risk Oversight & Management
Background as an advisor to multiple start-up companies provides Mr. Partovi
experience in the unique challenges facing companies pursuing new technology.
Axon Enterprise, Inc. | 2026 Proxy Statement | 16
Table of Contents
Sullivan_20230317_Smith_Graham_5349.jpg
Graham Smith
Director since 2023
Age: 66
Board Committees: Audit Committee (Chair), Compensation Committee, Mergers and Acquisitions
and Capital Structure Committee
Other Public Company Boards: Procore Technologies, Inc., GoDaddy, Inc.
Mr. Smith has served on the board of directors of Procore Technologies, Inc., a provider of cloud-based construction
management software, since 2020 and on the board of directors of GoDaddy, Inc., a provider of digital domains and
business management software for small business, since 2024. Mr. Smith previously served as chair of the board of
directors of Splunk Inc. from March 2019 through March 2024, and as a member of its board of directors from 2011
through 2024. He also served as the interim CEO of Splunk Inc. from November 2021 to April 2022.  Mr. Smith served in
various leadership positions at salesforce.com, inc. (“Salesforce”), a provider of enterprise cloud computing software,
from 2007 to 2015, including as Chief Financial Officer and most recently as Executive Vice President. Prior to joining
Salesforce, Mr. Smith served as Chief Financial Officer at Advent Software Inc., a portfolio accounting software
company, from 2003 to 2007. Mr. Smith previously served on the board of directors of BlackLine, Inc., a provider of
cloud-based solutions for finance and accounting, from 2015 to 2022; Citrix Systems, Inc., an enterprise software
company, from 2015 to 2018; MINDBODY, Inc., a cloud-based wellness services marketplace (acquired by Vista Equity
Partners), from 2015 to 2019; Xero Limited, an online accounting software company, from 2015 to 2020; Slack
Technologies, Inc., a provider of cloud-based professional collaboration tools (acquired by salesforce.com), from 2018 to
2021; and Elliott Opportunity II Corp., a special purchase acquisition company, from June to December 2021. Mr. Smith
holds a B.Sc. from Bristol University in England and qualified as a chartered accountant in England and Wales.
Specific Qualifications, Attributes, Skills and Experience:
Accounting/Auditing Experience
As an international chartered accountant, Mr. Smith has served as Chief
Financial Officer of multiple publicly traded companies.
Technology Expertise
Experience as an executive of multiple technology companies, including
leadership positions at Salesforce, provides expertise in technology
company operations.
Risk Oversight & Management; Public
Company Board Experience/Corporate
Governance
Board experience for Splunk Inc. and Procore Technologies, Inc., as well
as BlackLine, Inc., Citrix Systems, Inc., MINDBODY, Inc., Slack
Technologies, Inc. and Xero Limited, provides extensive insights into
public company corporate governance matters.
Rick Smith.jpg
Patrick Smith, CEO
Director since 1993
Age: 55
Board Committees: None
Other Public Company Boards: None
Mr. Smith has served as CEO and as a director of the Company since 1993. He is also co-founder of the Company. After
graduating from Harvard University, cum laude, in just three years (class of 1991), Mr. Smith entered directly into the
M.B.A. program at the University of Chicago. In two years, he completed both a master’s degree in international finance
from the University of Leuven in Leuven, Belgium and an M.B.A. with honors at the University of Chicago, graduating in
the top 5% of his class. After completing graduate school in the summer of 1993, he co-founded Axon Enterprise, Inc.
(F.K.A. TASER International, Inc.) in September 1993 with his brother, Thomas P. Smith. Among other qualifications,
Mr. Smith is the visionary of the Company and brings to the Board extensive executive leadership experience in the
technology industry, including the management of worldwide operations, sales, service and support as well as technology
innovation as he currently holds 53 U.S. patents.
Axon Enterprise, Inc. | 2026 Proxy Statement | 17
Table of Contents
Specific Qualifications, Attributes, Skills and Experience:
Technology Expertise
Mr. Smith is highly skilled in technology innovation and is the holder of 53 U.S.
patents.
Risk Oversight & Management
Management and board experience as the CEO and co-founder of the Company
provides extensive executive leadership expertise in navigating the range of risks
faced by the Company over the past 30+ years.
Jeri Williams - Headshot.jpg
Jeri Williams
Director since 2023
Age: 60
Board Committees: Enterprise Risk and Compliance Committee, Nominating and Corporate
Governance Committee
Other Public Company Boards: None
Ms. Williams served as Chief of Police for the Phoenix Police Department, the first female to lead the city’s force, from
2016 to 2022. During her tenure with the department, she advanced a number of progressive strategies, including key
areas such as community engagement and professional standards. Previously, she served nearly six years as the first
female Chief of Police in the City of Oxnard, California. Ms. Williams has received extensive accolades for her
dedication to law enforcement, including being named one of Arizona’s Most Intriguing Women by the Arizona
Centennial Legacy Project and recognized as California’s Assembly District 44 Woman of the Year for her leadership and
outstanding accomplishments. In 2016, President Obama appointed Ms. Williams to a membership position on the Medal
of Valor Review Board. She has also served as the first female President of the Major Cities Chiefs Association.  Since
2023, Ms.Williams has acted as Principal for Impresa Strategy, a business consulting and advisory services firm. Ms.
Williams holds a B.A. in Fine Arts from Arizona State University and a M.A. in Education from Northern Arizona
University.
Specific Qualifications, Attributes, Skills and Experience:
Governmental Experience
Service as the President of the Major Cities Chiefs Association provides valuable
insight into community engagement and enhances relationships with various
governmental agencies and law enforcement leaders.
Law Enforcement Experience
Service as Chief of Police for the Phoenix Police Department and City of Oxnard,
California provides deep insight into the operational demands of our law
enforcement customers.
Axon Enterprise, Inc. | 2026 Proxy Statement | 18
Table of Contents
BOARD AND COMMITTEE GOVERNANCE
Board Leadership Structure
Michael Garnreiter, Chair of the Board
Patrick Smith, CEO
The Company’s governance documents provide the Board with flexibility to select the appropriate leadership structure for
the Company. In making leadership structure determinations, the Board considers many factors, including the specific
needs of the business and what is in the best interests of the Company and its shareholders. The current leadership structure
is anchored by an independent director as Chair of the Board. If at any time the Chair of the Board is not independent, the
Board will elect a “Lead Independent Director” by a majority vote of the independent directors. The Lead Independent
Director will have the responsibilities described in our Corporate Governance Guidelines. The Board believes this structure
provides a well-functioning and effective balance between strong Company leadership and appropriate safeguards and
oversight by independent directors.
The principal role of the Chair of the Board is to manage and to provide leadership to the Board of Directors of the
Company. The Chair is accountable to the Board and acts as a direct liaison between the Board and the management of the
Company, through the CEO. The Chair acts as the communicator of Board decisions where appropriate. The separation of
the role of the Chair from that of the CEO is based on the Board’s view that the Chair should be free from any interest and
any business or other relationship that could interfere with the Chair’s judgment, other than interests resulting from
Company shareholdings and remuneration.
The NCG Committee oversees an annual evaluation of the performance and effectiveness of the Board and its standing
committees. The process is facilitated by independent outside counsel and includes confidential director feedback on
matters such as Board and committee composition, functioning, information flow, oversight, and overall effectiveness. The
findings are reviewed by the NCG Committee and the Board and are used to inform Board succession planning, committee
assignments, refreshment, and the identification of skills and experience priorities for director recruitment.
Axon’s key governance documents, including our Corporate Governance Guidelines, are available at https://
investor.axon.com/Governance-Documents.
Meetings of the Board of Directors
During the year ended December 31, 2025, the Board held five meetings. No member of the Board attended fewer than
75% of the total number of meetings of the Board (held during the period for which he or she was a director) and the total
number of meetings held by all committees of the Board on which such director served (held during the period that such
director served). Directors are encouraged by the Company to attend each annual meeting of shareholders if their schedules
permit. All directors serving on the board as of the 2025 Annual Meeting attended the meeting.
Axon Enterprise, Inc. | 2026 Proxy Statement | 19
Table of Contents
Committees of the Board of Directors
The Board currently has five standing committees: the Audit Committee, the Compensation Committee, the Nominating
and Corporate Governance Committee, the Enterprise Risk and Compliance Committee, and the Mergers and Acquisitions
and Capital Structure Committee. The following table summarizes the current membership of our standing non-
management Board committees, and identifies the chair of each committee and the number of committee meetings held in
fiscal 2025:
Audit
Committee
Compensation
Committee
Nominating and
Corporate
Governance
Committee
Enterprise
Risk and
Compliance
Committee
Mergers and
Acquisitions
and Capital
Structure
Committee
# Meetings
8
3
10
4
10
Director
Erika Ayers Badan
X
X
Adriane Brown
X
*
X
Julie Cullivan (1)
X
X
Michael Garnreiter (2)
X
X
X
Caitlin Kalinowski
X
*
Matthew McBrady (3)
X
*
Todd Morgenfeld
X
X
Hadi Partovi
*
X
Graham Smith (4)
*
X
X
Jeri Williams
X
X
X = Member
* = Chair
(1)Julie Cullivan is not standing for re-election to the Board upon expiration of her current term at the Annual Meeting. Ms.
Cullivan served as Chair of the Enterprise Risk and Compliance Committee and a member of the Audit Committee
through August 28, 2025 upon approval by the Board of Directors.
(2)Michael Garnreiter serves as Chair of the Board.
(3)Matthew McBrady is not standing for re-election to the Board upon expiration of his current term at the Annual
Meeting.
(4)There is no family relationship between Graham Smith and our CEO, Patrick Smith.
Audit Committee
The Audit Committee, established in accordance with Section 3(a)(58)(A) of the Exchange Act, assists the Board in
fulfilling its oversight responsibilities regarding (i) the Company’s process for financial reporting and the integrity of the
Company’s financial statements; (ii) the Company’s internal control system; (iii) the performance of the Company’s
internal audit function; (iv) the independent accountants’ independence, qualifications and performance; (v) the Company’s
risk assessment and management policies for major financial risks; and (vi) the Company’s Code of Business Conduct &
Ethics (“Code of Ethics”) and process for monitoring compliance with laws and regulations. In furtherance of its purpose,
the Audit Committee has the following specific responsibilities:
Discusses with management the Company’s major financial risk exposures and the steps management has taken to
monitor and control such exposures;
Discusses with management the Company’s liquidity, cash management and treasury functions, and provides
oversight of the Company’s Corporate Investment Policy;
Reviews and considers for ratification or approval all related party transactions and/or other transactions
implicating a potential conflict of interest between the Company and any of its directors, executive officers, 5%
shareholders or other related parties if such transactions are in excess of $120,000;
Periodically reviews the Company’s program for monitoring compliance with the Code of Ethics and receives and
reviews updates from management regarding the implementation of the Code of Ethics, including the annual
ethics certification and training processes of covered persons;
Axon Enterprise, Inc. | 2026 Proxy Statement | 20
Table of Contents
Establishes procedures for (i) the receipt, retention and treatment of complaints received by the Company
regarding internal accounting controls or accounting or auditing matters and (ii) the confidential, anonymous
submission by employees of the Company of concerns regarding internal accounting controls, questionable
accounting or auditing matters;
Periodically obtains any required reports and assurances from the independent accountants, the internal auditor
and management with respect to the effectiveness of the Company’s system for monitoring compliance with laws
and regulations; and
Receives and reviews reports from management with respect to any significant legal, compliance or regulatory
matters that may have a material impact on the Company’s business, financial statements or compliance policies,
including material notices to or inquiries received from governmental agencies.
With respect to any such matters that involve cybersecurity, data privacy or information technology, the Committee
coordinates and consults with the Enterprise Risk and Compliance Committee as appropriate.
The Audit Committee exercises sole authority with respect to the selection of the Company’s independent registered public
accounting firm and the terms of its engagement. The Audit Committee reviews with the independent registered public
accounting firm, upon the completion of its audit of the Company’s financial statements, the results of the auditing
engagement; reviews with the independent registered public accounting firm, upon the completion of its quarterly review
of the Company’s financial statements, the results of the quarterly review; and at least annually meets with the independent
registered public accounting firm to review any recommendations they may have with respect to the Company’s financial,
accounting or auditing systems.
The Report of the Audit Committee for the year ended December 31, 2025 is included in this proxy statement. See “Audit
Matters—Report of the Audit Committee” for more information regarding the Audit Committee.
The Audit Committee’s primary responsibilities are set forth in its charter, which is subject to annual review and revision.
The full text of the Audit Committee charter is available on our website at https://investor.axon.com/Governance-
Documents.
Compensation Committee
The Compensation Committee assists the Board in discharging its responsibilities regarding the compensation of the
officers of the Company within the meaning of Section 16 of the Exchange Act (collectively, “Section 16 Officers”) and
members of the Board. The Compensation Committee is responsible for (i) overseeing the Company’s compensation plans,
policies and programs to appropriately retain individuals and incentivize performance in alignment with shareholder value
creation, (ii) assessing the appropriateness of their compensation in light of business, competitive and regulatory
considerations and (iii) evaluating the performance of the Section 16 Officers. In addition, the Compensation Committee
oversees compensation plans, policies and programs applicable to the Company’s directors, Section 16 Officers and other
employees, including equity-based plans such as the design of the Axon Enterprise, Inc. Amended and Restated 2022 Stock
Incentive Plan, the Axon Enterprise, Inc. eXponential Stock Plan and the CEO Performance Award (as defined below).
The Compensation Committee also oversees, in consultation with the NCG Committee, the Company’s policies, practices
and initiatives relating to human capital management, including workforce diversity, workplace culture, talent
development, retention and recruitment and employee engagement.
The Compensation Committee Report for the year ended December 31, 2025 is included in this proxy statement. See
“Executive Compensation—Compensation Discussion and Analysis—Compensation Committee Report” for more
information regarding the Compensation Committee.
The Compensation Committee’s primary responsibilities are set forth in its charter, which is subject to annual review and
revision. The full text of the Compensation Committee charter is available on our website at https://investor.axon.com/
Governance-Documents.
Axon Enterprise, Inc. | 2026 Proxy Statement | 21
Table of Contents
Nominating and Corporate Governance Committee
The Nominating and Corporate Governance Committee assists the Board in overseeing (i) the process by which individuals
are nominated to become Board members; (ii) matters of corporate governance, including advising the Board on matters of
(A) Board organization, membership and function, such as Board evaluations, new Board member on-boarding and Board
continuing education programs and (B) committee structure and membership; (iii) oversight of the Company's policy on
political spending and related disclosures; and (iv) succession planning for Board members and executive officers of the
Company.
In addition, in collaboration with other committees of the Board and the Company’s management as appropriate, the
Nominating and Corporate Governance Committee identifies and monitors emerging corporate governance issues and
trends that could be reasonably expected to have a substantial impact on the Company, including any material
environmental or sustainability-related issues and the Company’s strategy with respect to social matters of significance to
the Company.
The Nominating and Corporate Governance Committee also periodically reviews the Company’s Corporate Governance
Guidelines and other corporate governance policies and recommends to the Board any changes that the Committee
determines, in its sole discretion, to be necessary or appropriate. Our Corporate Governance Guidelines reflect our
commitment to corporate governance best practices.
The Nominating and Corporate Governance Committee’s primary responsibilities are set forth in its charter, which is
subject to annual review and revision. The full text of the Nominating and Corporate Governance Committee charter is
available on our website at https://investor.axon.com/Governance-Documents.
Other Standing Committees
The Enterprise Risk and Compliance Committee
The Enterprise Risk and Compliance Committee assists the Board in overseeing our overall approach to enterprise risk
management and regularly reviews the categories of risk the Company faces. The Committee is also responsible for
overseeing the design, implementation and management of an effective information security program, including reviewing
and overseeing the Company’s policies and procedures relating to cybersecurity and data protection risks associated with
the Company’s products, services, information technology infrastructure and related operations. In addition, the Committee
oversees the Company’s artificial intelligence governance framework, which includes policies, processes, and technical
controls designed to ensure that artificial intelligence technologies are used responsibly, ethically, safely, and legally.
The Mergers and Acquisitions and Capital Structure Committee
The Mergers and Acquisitions and Capital Structure Committee serves to focus on issues related to any proposed merger,
acquisition or other strategic investment activity or plans identified by the Company’s management. It also provides
guidance and oversight on the Company’s financing decisions.
Director Independence
As of the date of this proxy statement, based upon the information submitted by each of its directors, the Board has made a
determination that a majority of our current Board is independent as that term is defined by the listing standards of The
Nasdaq Stock Market (the “NASDAQ Listing Standards”) and that all of the members of our Board committees also meet
any additional specific independence standards applicable to any committee on which such director serves, including the
more stringent audit committee and compensation committee independence criteria. In addition, each of the members of
our Compensation Committee is also a “non-employee director” (within the meaning of Rule 16b-3 under the Exchange
Act).
For 2025, the Company determined that all Board members, other than Patrick Smith and Matthew McBrady, were
independent under the applicable NASDAQ Listing Standards and SEC rules. Mr. P. Smith and Mr. McBrady are not
independent. Mr. P. Smith is not considered independent as he is the founder and CEO of the Company. Out of an
abundance of caution, the Board determined that Mr. McBrady is not independent given his long-standing social
relationship with Mr. P. Smith.
Axon Enterprise, Inc. | 2026 Proxy Statement | 22
Table of Contents
Audit Committee Financial Experts
The Board of Directors determined that Michael Garnreiter, Graham Smith and Todd Morgenfeld, each an independent
director of the Company, is an audit committee financial expert within the meaning of that term under applicable SEC
rules. See “Governance—The Board of Directors” for information about the past business and educational experience of
each of Mr. Garnreiter, Mr. G. Smith, and Mr. Morgenfeld. The Board has determined that each of the members of our
Audit Committee is financially literate and that each of Mr. Garnreiter, Mr. G. Smith and Mr. Morgenfeld satisfies the
financial sophistication requirements under the NASDAQ Listing Standards.
Board of Directors’ Role in Risk Oversight
The Company’s risk management process is intended to ensure that risks are taken knowingly and purposefully. The Board
has allocated and delegated primary responsibility for risk oversight responsibility to its committees: the Audit Committee,
the Compensation Committee, the NCG Committee, the Enterprise Risk and Compliance Committee and the Mergers and
Acquisitions and Capital Structure Committee.
The Audit Committee meets at least once a quarter and is responsible for oversight of the Company’s major financial risk
exposures and the steps management has taken to monitor and control such exposures. The Company maintains an internal
audit function that reports directly to the Audit Committee Chair and reports to the Audit Committee quarterly on the status
and health of internal controls. The Chief Legal Officer reports to the Audit Committee quarterly on potential ethics
complaints as well as the status of the Company’s pending litigation and any potential related party transactions. The Audit
Committee in turn reports to the full Board on the status of financial risks and internal controls at least once a quarter.
The Compensation Committee meets as needed and is responsible for oversight of the Company’s risks relating to its
compensation plans, policies and programs, as well as human capital management, including workforce diversity,
workplace culture, talent development, retention and recruitment and employee engagement. The Compensation
Committee reports regularly to the full Board regarding its activities.
The NCG Committee meets as needed and is responsible for oversight of risks relating to the Company’s corporate
governance practices and emerging corporate governance issues and trends that could be reasonably expected to have a
substantial impact on the Company, including any material environmental or sustainability-related issues and the
Company’s strategy with respect to social matters of significance to the Company. The NCG Committee reports regularly
to the full Board regarding its activities.
The Enterprise Risk and Compliance Committee typically meets at least quarterly and is responsible for oversight of the
Company’s information security, compliance and enterprise risks excepting the financial risks overseen by the Audit
Committee. Specifically, the Enterprise Risk and Compliance Committee provides oversight of the Company’s
cybersecurity and systems integrity practices, data protection, and risks and governance related to artificial intelligence. In
addition, the Enterprise Risk and Compliance Committee provides oversight of the Company’s compliance practices
(including import compliance, export compliance, Bureau of Alcohol, Tobacco & Firearms compliance, anti-bribery and
corruption compliance, modern slavery and anti-human trafficking compliance, labor and employment compliance,
workplace safety, data privacy, lobbying compliance and antitrust compliance). Enterprise Risk and Compliance
Committee meetings are informed by management who maintain a risk dashboard to monitor company-wide risks and
prioritize them based on potential likelihood and potential severity of impact to the Company. Risk mitigation strategies are
tracked and reported on by management to the Enterprise Risk and Compliance Committee at least once a quarter.
Likewise, the Enterprise Risk and Compliance Committee reports to the full Board on the highest priority risks and
mitigation strategies at least once a quarter.
The Mergers and Acquisitions and Capital Structure Committee typically meets at least quarterly and is responsible for
oversight of risks relating to the Company’s merger, acquisition or other strategic investment activity or plans identified by
the Company’s management. It also provides guidance and oversight on the Company’s financing decisions. The Mergers
and Acquisitions and Capital Structure Committee reports regularly to the full Board regarding its activities.
Axon Enterprise, Inc. | 2026 Proxy Statement | 23
Table of Contents
Corporate Compliance and Governance Principles
Corporate Governance Guidelines
Our Corporate Governance Guidelines address a broad set of issues integral to sound governance:
+ Board structure and composition
+ Risk oversight
+ Director independence
+ Management performance and compensation
+ Evaluation of board leadership
+ Conflicts of interest
+ Majority voting for directors
+ Director retirement policy
+ Board and executive succession planning
+ Director orientation and continuing education
+ Director responsibilities
Our Board reviews our Corporate Governance Guidelines periodically, updating them from time to time as regulatory
requirements change and governance practices evolve. Our Nominating and Corporate Governance Committee is
responsible for overseeing our Corporate Governance Guidelines and for reporting and making recommendations to our
Board concerning corporate governance matters. Our Corporate Governance Guidelines are available at https://
investor.axon.com/Governance-Documents.
Succession Planning
The NCG Committee oversees succession planning for the Board and for the executive officers of the Company and its
subsidiaries, both in the ordinary course and in anticipation of a potential unexpected departure. With respect to Board
succession, the NCG Committee regularly reviews the Board’s composition against a candidate criteria document that it
updates based on the results of the Board’s annual self-evaluation, the Company’s evolving strategic needs, and the tenure
and expected succession horizon of current directors. The Committee retains a third-party executive search firm from time
to time to source and screen candidates, and oversees a multi-step vetting and interview process before recommending
nominees to the full Board for appointment. The Committee also plans for succession of the Chair of the Board and each
committee chair, taking into account tenure, relevant skill sets, and the governance needs of the Board. With respect to
executive succession, the Board considers leadership depth and continuity to be a governance priority. On an annual basis,
senior management presents the full Board with a succession review covering the Chief Executive Officer and other key
executive roles, identifying internal candidates at various stages of readiness and noting any gaps that may warrant
development or external recruitment. Directors also interact with senior management throughout the year—at formal Board
and committee meetings and in less formal settings—which supports the Board’s direct assessment of management depth
and the strength of the Company’s leadership pipeline.
Code of Ethics
We are proud of the values with which we conduct our business. All employees, officers, contractors and directors of Axon
are required to abide by our Code of Ethics to help ensure that we consistently uphold the highest levels of business ethics
and personal integrity in all transactions and interactions, both internally and in dealings with our customers, vendor and
suppliers. We have also adopted a separate code of ethics for senior financial officers (the “Senior Financial Officer Code
of Ethics”) that is applicable to the CEO, Chief Financial Officer, Chief Accounting Officer, Vice President of Financial
Reporting and Strategic Investments, and others performing similar functions. Our Audit Committee assists our Board in
fulfilling its oversight responsibility as to our compliance with the goals and objectives in our Code of Conduct by
reviewing and taking action regarding compliance processes, standards and controls and reviewing results of relevant
audits and investigations.
Axon Enterprise, Inc. | 2026 Proxy Statement | 24
Table of Contents
Our Code of Ethics covers a broad range of topics, including:
+ Expectations to conduct all Company business in accordance with applicable laws, rules, and regulatory requirement;
+ Adherence to fair competition, anti-corruption, and data protection laws;
+ Prohibition of financial or other interests that might conflict with the best interests of the Company;
+ Strict restrictions on insider trading, including trading limitations that apply to all directors, officers and employees
during designated periods;
+ Expectation to engage in honest, fair, and transparent dealings with customers, suppliers, competitors, and colleagues;
+ Commitment to equal employment opportunities and non-discrimination in hiring, promotions and workplace practices;
and
+ Prohibition of all forms of harassment, including sexual harassment, workplace bullying, and other inappropriate
behavior.
Our Senior Financial Officer Code of Ethics covers a broad range of topics, including:
+ Requirements to bring any material information that may affect disclosure in public filings as well as any deficiencies in
internal controls to the attention of the general counsel or CEO;
+ Prohibitions on actual or apparent conflicts of interest between personal and business relationships; and
+ Expectations to act with honesty and integrity.
A copy of the Company’s Code of Ethics and Senior Financial Officer Code of Ethics are published and available on our
website at https://investor.axon.com/Governance-Documents. The Company intends to disclose any future amendments or
waivers to the Code of Ethics and the Senior Financial Officer Code of Ethics that are required to be disclosed on the
Company’s website within four business days following the date of such amendment or waiver.
Shareholder Communications with Directors
Shareholders may communicate with members of the Board by mail addressed to the Chair, or any other individual
member of the Board, to the full Board, or to a particular committee of the Board. In each case, such correspondence
should be sent to the Company’s headquarters at 17800 North 85th Street, Scottsdale, AZ 85255. In general, any
shareholder communication about bona fide issues concerning the Company delivered to the Corporate Secretary for
forwarding to the Board or specified members will be forwarded in accordance with the shareholder’s instructions.
Axon Enterprise, Inc. | 2026 Proxy Statement | 25
Table of Contents
DIRECTOR COMPENSATION
Members of the Board who are employees of the Company are not separately compensated for serving on the Board. Board
compensation is reviewed periodically by the Company’s Compensation Committee. Non-employee directors of the
Company are paid $10,000 in cash per quarter and are eligible to receive annual grants of restricted stock units (“RSUs”)
with a grant date fair value equal to approximately $260,000 vesting on the one-year anniversary of the grant. New Board
members are eligible to receive an initial grant of RSUs with a grant date fair value equal to approximately $260,000 in
their first year of service vesting in equal annual installments over three years. The Chair of the Board receives an
additional (i) $5,000 in cash per quarter and (ii) an annual grant of RSUs with a grant date fair value equal to
approximately $20,000 vesting on the one-year anniversary of the grant date. Board members who provide any special
Board advisory consultations in their official capacity as Board members (other than Board and committee meetings) are
compensated at the rate of $2,500 per day or $1,250 per half day, with no pay for travel days. All directors are reimbursed
for reasonable expenses incurred in connection with their attendance at meetings.
In addition, for the fiscal year ended December 31, 2025, Board members serving on committees in either the chair or
member capacity received fees as summarized in the following table:
Committee
Annual
Chair Fee
Annual
Member Fee
Audit
$25,000
$10,000
Compensation (1)
25,000
7,500
Nominating and Corporate Governance
10,000
5,000
Mergers and Acquisitions and Capital Structure
10,000
6,000
Enterprise Risk and Compliance
10,000
6,000
(1) The annual Chair fee for the Compensation Committee increased effective July 1, 2025 from $15,000 to $25,000
following the Compensation Committee’s review in 2024. Refer to the prior year proxy statement for more
information.
The annual RSU awards are typically granted on the date of the Company’s annual meeting of shareholders. Directors have
the option of deferring all or a portion of their cash compensation into the TASER International, Inc. Deferred
Compensation Plan, the Company’s non-qualified deferred compensation plan (the “Deferred Compensation Plan”).
In 2024, the Compensation Committee engaged Semler Brossy Consulting Group, LLC (“Semler Brossy”) as its
independent compensation consultant. Semler Brossy provided research, data analysis, and benchmarking services to assist
the Committee in evaluating and adjusting director compensation. The director compensation data utilized was consistent
with the peer group identified by Semler Brossy during their 2023 executive compensation review. The Compensation
Committee’s philosophy is to generally set director compensation at approximately the 50th percentile of the peer group,
with adjustments reviewed and implemented every three years. Based on the review performed in 2024, adjustments to
director compensation were made which became effective in 2025 as described above.
Axon Enterprise, Inc. | 2026 Proxy Statement | 26
Table of Contents
The following table summarizes the compensation paid to non-employee directors for the fiscal year ended December 31,
2025.
Name
Fees Earned or
Paid in Cash
($)
Stock Awards
($) (1) (2)
All Other
Compensation
($)
Total ($)
Current Directors
Erika Ayers Badan
$46,875
$325,709
$
$372,584
Adriane Brown
63,500
325,709
389,209
Julie Cullivan (3)
61,500
325,709
387,209
Michael Garnreiter
82,500
351,269
433,769
Caitlin Kalinowski
57,000
325,709
382,709
Matthew McBrady
58,500
325,709
384,209
Todd Morgenfeld
19,231
262,718
281,949
Hadi Partovi
66,000
325,709
391,709
Graham Smith
78,500
325,709
404,209
Jeri Williams
54,750
325,709
380,459
(1)Amounts in this column represent the aggregate grant date fair value of RSUs, computed in accordance with
stock-based compensation accounting rules in Financial Accounting Standards Board Accounting Standards
Codification Topic 718, Compensation—Stock Compensation (“ASC Topic 718”). The fair value of each RSU is
the closing price of our common stock on the date of grant. Each of our current non-employee directors, except
Mr. Morgenfeld, received an award of 446 RSUs on May 29, 2025, each of which will vest on the one-year
anniversary of the grant on May 29, 2026. Mr. Morgenfeld received an award of 336 RSUs on August 28, 2025
following his appointment, vesting annually over three years. Pursuant to SEC regulations, the amounts shown
exclude the impact of estimated forfeitures related to service-based vesting conditions. The assumptions used in
the calculations of the grant date fair values for such awards are included in Note 1 to our consolidated financial
statements for the fiscal year ended December 31, 2025 within our 2025 Annual Report.
The following table shows the aggregate number of RSUs outstanding for each director as of December 31, 2025.
Name
Aggregate
Restricted Stock
Units Outstanding
Erika Ayers Badan
793
Adriane Brown
446
Julie Cullivan
446
Michael Garnreiter
481
Caitlin Kalinowski
446
Matthew McBrady
446
Todd Morgenfeld
336
Hadi Partovi
446
Graham Smith
753
Jeri Williams
753
(2)Pursuant to his service as Chair of the Board, on May 29, 2025, Mr. Garnreiter received a grant of 35 restricted
shares, which will vest on the one-year anniversary of the grant date.
Axon Enterprise, Inc. | 2026 Proxy Statement | 27
Table of Contents
(3)Non-employee directors have the option of participating in the Deferred Compensation Plan through which
participants may elect to postpone the receipt and taxation of a portion of their cash compensation. All gains or
losses are allocated fully to participants and the Company does not guarantee a rate of return on deferred balances.
The Company does not make discretionary payments to the plan. There were no above-market returns for
participants in the plan. Ms. Cullivan chose to participate in the Deferred Compensation Plan and elected to defer
$61,500 of earned compensation into the plan during the year ended December 31, 2025.
Director Stock Ownership Guidelines
The Board adopted stock ownership guidelines in December 2018. The stock ownership guidelines require that non-
employee directors hold Company stock equivalent to five times the dollar value of their base cash compensation; for 2025,
this equates to $200,000. New non-employee directors have up to three years to meet this requirement. If a director falls
below this requirement, he or she is not allowed to sell shares until the requirement is met. All non-employee directors are
in compliance with these guidelines.
Axon Enterprise, Inc. | 2026 Proxy Statement | 28
Table of Contents
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
The Company reviews all relationships and transactions in which the Company and its directors, director nominees,
executive officers or their immediate family members are participants, to determine whether such persons have a direct or
indirect material interest. Management is primarily responsible for the development and implementation of processes and
controls to obtain information from the directors and executive officers with respect to related party transactions and for
then determining, based on the facts and circumstances, whether the Company or a related party has a direct or indirect
material interest in the transaction. As required under SEC rules, transactions that are determined to be directly or indirectly
material to us or a related party are disclosed in this proxy statement.
The Company has a written related party policy, which is included within the Audit Committee Charter, wherein the Audit
Committee reviews, approves or ratifies related party transactions in accordance with the NASDAQ Listing Standards. It is
the policy of the Company that all proposed transactions in excess of $120,000 between the Company and its directors,
officers, 5% shareholders and their affiliates should be entered into or approved only if such transactions are on terms no
less favorable to the Company than it could obtain from unaffiliated parties, are reasonably expected to benefit the
Company and are disclosed to the Audit Committee. The Audit Committee is authorized to consult with independent legal
counsel at the Company’s expense in determining whether to approve any such transaction.
Axon Enterprise, Inc. | 2026 Proxy Statement | 29
Table of Contents
SHARE OWNERSHIP
OWNERSHIP OF EQUITY SECURITIES OF THE COMPANY
The following table sets forth information, as of March 31, 2026, with respect to beneficial ownership of the Company’s
common stock by each current director or nominee for director, by each of our named executive officers as defined by Item
402(a)(3) of Regulation S-K (the “NEOs”), by all directors and executive officers as a group, and by each person who is
known to the Company to be the beneficial owner of more than 5% of the Company’s outstanding common stock. The
Company believes that, except as otherwise described below, each named beneficial owner has sole voting and investment
power with respect to the shares listed.
Name of Beneficial Owner (1)
Shares
Beneficially
Owned
Shares
Acquirable
Within 60
Days (2)
Total
Beneficial
Ownership
Percent of
Class (3)
Beneficial Owners of More than 5%:
BlackRock, Inc. (4)
7,486,272
7,486,272
9.3 %
The Vanguard Group (5)
9,314,070
9,314,070
11.6 %
Directors and Named Executive Officers:
Patrick Smith (6)
2,789,952
20,931
2,810,883
3.5 %
Hadi Partovi (7)
237,592
446
238,038
*
Michael Garnreiter
17,259
481
17,740
*
Julie Cullivan
1,735
446
2,181
*
Caitlin Kalinowski
3,139
446
3,585
*
Matthew McBrady
3,492
446
3,938
*
Adriane Brown
7,380
446
7,826
*
Graham Smith
2,572
446
3,018
*
Jeri Williams
713
446
1,159
*
Todd Morgenfeld
*
Erika Ayers Badan
1,153
446
1,599
*
Joshua Isner (8)
114,531
114,531
*
Brittany Bagley (9)
52,229
52,229
*
Jeffrey Kunins (10)
117,621
117,621
*
Cameron Brooks
15,995
15,810
31,805
*
All directors and executive officers as a group (15 persons)
3,365,363
40,790
3,406,153
4.2 %
*Less than 1%
(1)Except as noted in Notes 4 and 5 below, the address of each person or group of persons listed above is c/o Axon
Enterprise, Inc., 17800 North 85th Street, Scottsdale, AZ 85255.
(2)Reflects the number of shares that could be purchased by exercise of options exercisable at March 31, 2026, or
awards vesting within 60 days thereafter under the Company’s stock incentive plans.
(3)Based on 80,572,201 shares outstanding as of March 31, 2026. For purposes of computing the percentage of
outstanding shares of our common stock held by each person or group of persons listed above, any security that
such person or group has the right to acquire within 60 days of March 31, 2026 is deemed to be outstanding.
Axon Enterprise, Inc. | 2026 Proxy Statement | 30
Table of Contents
(4)Represents shares of the Company’s common stock beneficially owned based on the Schedule 13G/A filed on
January 21, 2026 by BlackRock, Inc. In such filing, BlackRock, Inc. lists its address as 50 Hudson Yards New
York, NY 10001, and indicates it has sole voting power with respect to 6,992,413 shares of the Company’s
common stock, shared voting power with respect to no shares of the Company’s common stock, sole dispositive
power with respect to 7,486,272 shares of the Company’s common stock, and shared dispositive power with
respect to no shares of the Company’s common stock.
(5)Represents shares of the Company’s common stock beneficially owned based on the Schedule 13G/A filed on
October 30, 2025 by The Vanguard Group. In such filing, The Vanguard Group lists its address as 100 Vanguard
Blvd., Malvern, PA 19355, and indicates it has sole voting power with respect to no shares of the Company’s
common stock, shared voting power with respect to 470,289 shares of the Company’s common stock, sole
dispositive power with respect to 8,566,941 shares of the Company’s common stock, and shared dispositive power
with respect to 747,129 shares of the Company’s common stock Based on the Schedule 13G/A filed on March 26,
2026, The Vanguard Group reported that, due to an internal realignment on January 12, 2026, it no longer has, or
is deemed to have, beneficial ownership of our common stock beneficially owned by various subsidiaries or
business divisions of The Vanguard Group. The Vanguard Group also reported that certain subsidiaries or
business divisions that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group
will report their beneficial ownership separately (on a disaggregated basis) from The Vanguard Group.
(6)Mr. Smith holds 6,193 shares of the Company’s common stock in a joint account with his spouse, over which Mr.
Smith has shared voting and investment power.
(7)Includes 209,691 shares of the Company’s common stock owned directly by Mr. Partovi in standard margin
accounts and pledged as collateral to secure certain personal indebtedness. Such pledge is exempt from the
pledging limitation outlined in the Insider Trading Policy as it predates the effective date of such limitation. Based
on daily trading volume and the collateral representation of these shares, in conjunction with other personal assets,
the Board believes that this position does not pose a significant risk to shareholders or the Company.
(8)Includes 14,416 shares of the Company’s common stock owned directly by Mr. Isner in a revocable trust of which
he is co-trustee with his spouse. Mr. Isner has sole voting and investment power.
(9)Includes 6,923 shares of the Company’s common stock owned directly by Ms. Bagley in revocable trusts of which
she is co-trustee with her spouse. Ms. Bagley has shared voting and investment power.
(10)Includes 70,593 shares of the Company’s common stock owned indirectly Mr. Kunins through an LLC of which
he is the sole member.
Axon Enterprise, Inc. | 2026 Proxy Statement | 31
Table of Contents
EXECUTIVE COMPENSATION
NAMED EXECUTIVE OFFICERS
See “Governance—The Board of Directors” for biographical information for Patrick Smith, who is also our CEO.
Sullivan_20230316_Isner_Josh_5040 (1).jpg
Joshua Isner
Title: President
Joined Axon in 2009
Age: 40
As President, Mr. Isner is responsible for Axon’s execution and driving its growth — including top line execution and
global expansion into new markets and new product categories — and managing other day-to-day functions. Mr. Isner
joined Axon in 2009 as a member of Axon’s Leadership Development Program and quickly established a strong track
record of delivering results. In 2014, Mr. Isner led Axon’s domestic body camera and cloud software sales team to a
record year and was subsequently promoted to Executive Vice President of Global Sales. In 2018, he stepped into the role
of Chief Revenue Officer, responsible for Axon’s global growth, customer service, professional services and sales
operations, successfully driving annual growth rates in excess of 25%. Mr. Isner was tapped to be Axon’s Chief Operating
Officer in 2022 and was shortly thereafter promoted to President in 2023. He is a keen operational leader who drives
discipline and prioritization across the business, and ensures that Axon is aggressively pursuing our total addressable
market opportunity, supported by a world-class team. Mr. Isner has a B.S. in Government & Political Science from
Harvard University.
Sullivan_20230317_Bagley_Brittany_5829 (1).jpg
Brittany Bagley
Title: Chief Operating Officer and Chief Financial Officer
Joined Axon in 2022
Age: 42
Ms. Bagley serves as Axon’s Chief Operating Officer and Chief Financial Officer with responsibility for further
integrating Axon’s financial functions with its operations, including manufacturing, supply chain and enterprise. Ms.
Bagley is also responsible for driving operational improvements to contribute to the strength of Axon’s income statement,
balance sheet and statement of cash flows, including through more streamlined management of cost of goods sold,
inventory and working capital. She joined the Company’s management team in September 2022 after serving as Chief
Financial Officer of Sonos, Inc. since April 2019. Ms. Bagley also served on the board of directors of Sonos, Inc. from
September 2017 to April 2019. From December 2017 to April 2019, Ms. Bagley served as a Managing Director of
Kohlberg Kravis Roberts & Co. L.P. (together with its affiliates, “KKR”), a global investment firm, and previously served
in other roles at KKR from July 2007 to December 2017. Prior to joining KKR, Ms. Bagley was an analyst at The
Goldman Sachs Group, Inc., an investment banking firm. Ms. Bagley has served on the board of directors of Aurora
Innovation, Inc., a self-driving technology company, since July 2021 and is currently the chair of its audit committee and
a member of its compensation committee. Ms. Bagley holds a B.A. in Economics, magna cum laude, from Brown
University.
Axon Enterprise, Inc. | 2026 Proxy Statement | 32
Table of Contents
Sullivan_20230316_Kunins_Jeff_4652 (1).jpg
Jeffrey Kunins
Title: Chief Product Officer and Chief Technology Officer
Joined Axon in 2019
Age: 51
Mr. Kunins leads Axon’s global product, software and hardware engineering, artificial intelligence, design and security
teams — building Axon’s complete product suite, including body and in-car cameras, non-lethal de-escalation tools such
as TASER energy weapons, and Software-as-a-Service platforms for digital evidence management, productivity and real-
time operations. Since joining Axon in September 2019, Mr. Kunins has driven transformational expansion and up-
leveling of Axon’s global research and development organization and its ability to invent and deliver at scale. Prior to
Axon, Mr. Kunins served as Vice President of Alexa Entertainment at Amazon from February 2018. Mr. Kunins served as
the Vice President of Kindle at Amazon from March 2014 to February 2018. Prior to Amazon, Mr. Kunins served as
General Manager (“GM”) of Product and Design at Skype, GM of Windows Live Messenger at Microsoft and Vice
President of Product at Tellme Networks, Inc. Mr. Kunins has a B.S. in Information & Decision Systems from Carnegie
Mellon University.
Cameron Brooks.jpg
Cameron Brooks
Title: Chief Revenue Officer
Joined Axon in 2024
Age: 56
Mr. Brooks leads the strategy and execution of international sales, as well as global services and customer success at
Axon. Prior to Axon, Mr. Brooks was General Manager of Europe, Middle East and Africa Public Sector for Amazon
Web Services (“AWS”) where he served since December 2017. Prior to AWS, Mr. Brooks served in various key roles at
IBM, including Director of Public Sector for IBM’s Watson Group, Public Sector Leader for IBM’s Middle East & Africa
organization, and the Director of IBM’s Government Healthcare business. Mr. Brooks holds a B.S. in Electrical
Engineering from the University of Waterloo, Canada, and MS and PhD degrees in Electrical Engineering from the
University of Michigan. He also holds an MBA degree from the New York University Stern School of Business.
Each executive officer serves at the discretion of our Board of Directors and we have entered into employment-related
agreements with each of the executive officers listed above. These agreements require notice of termination by the
Company in certain situations that are described in further detail in this proxy statement. See “Executive Compensation—
Compensation Discussion and Analysis—Employment Agreements and Other Arrangements with NEOs.”
Axon Enterprise, Inc. | 2026 Proxy Statement | 33
Table of Contents
EXECUTIVE OFFICERS - NON-NEO
In addition to our Named Executive Officers, our leadership team includes the following executive officers:
Isaiah Fields.jpg
Isaiah Fields
Title: Chief Legal Officer
Joined Axon in 2011
Age: 49
Mr. Fields is responsible for overseeing Axon’s legal operations, government affairs, risk management and compliance.
Mr. Fields joined Axon in 2011 as litigation counsel and subsequently held positions including VP of Legal and
Government Affairs and SVP & General Counsel before being promoted to EVP & General Counsel in January 2021,
where he was responsible for overseeing Axon’s legal, medical and compliance departments. In his tenure at Axon, Mr.
Fields has negotiated record-breaking contracts for the company, and led strategies to significantly curtail product
litigation and protect Axon’s innovative intellectual property rights. Additionally, Mr. Fields was named 2021 General
Counsel of the Year for medium-sized public companies by Arizona’s Corporate Council Awards. Previously, Mr. Fields
served as an Assistant Attorney General at the Arizona Attorney General’s Office, representing the state in complex civil
litigation. Mr. Fields holds a Bachelor of Arts and Juris Doctorate from Hofstra University.
Elizabeth Hart.jpg
Elizabeth Coughlin (Hart)
Title: Chief Human Officer
Joined Axon in 2019
Age: 40
Ms. Hart is responsible for leading the company’s global People Operations organization. Prior to joining Axon in 2019,
Ms. Hart was the CAO for Trax Group, a SaaS-based startup from July 2016 to January 2019, and spent five years at
Bloomberg LP from April 2011 to July 2016. While at Bloomberg she held a variety of global roles including Interim
Recruiting Lead for Asia, HR Leader for the Industry Verticals and Chief of Staff for Bloomberg Government. Ms. Hart
holds a BS in Business Administration from the University of Mary Washington.
Axon Enterprise, Inc. | 2026 Proxy Statement | 34
Table of Contents
COMPENSATION DISCUSSION AND ANALYSIS
Our Named Executive Officers
The purpose of this Compensation Discussion and Analysis is to provide material information about our compensation
objectives and policies, with a focus on explaining and providing context for the material elements of the disclosure which
follows in this proxy statement with respect to the compensation of our NEOs in fiscal year 2025. For fiscal year 2025, our
NEOs are:
Patrick Smith, our CEO;
Joshua Isner, our President;
Brittany Bagley, our Chief Operating Officer and Chief Financial Officer;
Jeffrey Kunins, our Chief Product Officer and Chief Technology Officer; and
Cameron Brooks, our Chief Revenue Officer.
Our Compensation Philosophy
The Compensation Committee oversees matters relating to the fair and competitive compensation of our NEOs and non-
employee directors, together with matters relating to our compensation plans, policies and programs. The Compensation
Committee believes our executive compensation program should be market competitive to attract and retain highly
qualified individuals who are capable of making significant contributions critical to our long-term success, and
predominately delivered in the form of performance-based awards, including equity-based awards, which are designed to
promote incentives that are aligned with long-term shareholder interests. The objectives of our NEO compensation
programs include:
Attracting and retaining highly qualified individuals who are capable of making significant contributions critical
to our long-term success;
Promoting a performance-oriented environment that encourages Company and individual achievement;
Rewarding NEOs for long-term strategic management and the enhancement of shareholder value;
Strengthening the relationship between pay and performance by emphasizing variable, at-risk compensation that is
dependent upon the achievement of specified corporate and personal performance goals; and
Aligning long-term management interests with those of shareholders, including through long-term at-risk pay.
At the 2024 Annual Meeting, shareholders approved the Amended and Restated 2022 Stock Incentive Plan, the Employee
XSP and the CEO Performance Award (each as defined below). This marked the start of several new long-term equity
compensation programs. At the 2025 Annual Meeting, shareholders approved our overall compensation program for fiscal
year 2024 (referred to as the “say-on-pay” vote). The grants that were made in accordance with shareholder approval are
detailed below.
Axon Enterprise, Inc. | 2026 Proxy Statement | 35
Table of Contents
Shareholder Compensation Feedback and Our Response
Feedback Themes
What We Heard
Actions Taken in Response
Alignment between pay and
performance
Shareholders expressed a preference
for compensation outcomes that reflect
the Company’s performance
Performance-based awards granted as
part of the CEO Performance Award
and the Employee XSP will only vest if
various stock price goals and
operational performance hurdles are
met
Compensation arrangements structured
to promote long-term shareholder value
creation
Shareholders expressed a preference
for the integration of metrics that
encourage long-term shareholder value
creation
Equity awards earned by executives as
part of the CEO Performance Award
and the Employee XSP are tied to
various stock price goals and
operational performance hurdles that
will lead to long-term shareholder
value creation over an extended
performance period if achieved
Compensation arrangements structured
to promote retention of key executives
Shareholders expressed a preference
for executive compensation programs
that balance the use of time-based and
performance-based equity awards to
promote retention of key executives
Vesting of awards granted as part of
the CEO Performance Award and
Employee XSP is subject to minimum
service requirements
Use of one-time or special awards
Shareholders expressed concern about
the use of special awards to retain and
motivate key executives
The CEO Performance Award and the
Employee XSP are intended to take the
place of traditional performance-based
equity compensation programs rather
than function as special or one-time
awards. No additional stock awards
were granted to executives in 2025
Size of equity awards granted to
executives
Shareholders expressed concern about
the size of the awards granted to
executive officers in 2024
The equity awards granted to
executives in 2024 will cover seven
years of performance-based equity as
part of the CEO Performance Award
and Employee XSP
Consistency in compensation structure
Shareholders expressed a preference
for consistent compensation structures,
without significant changes to short- or
long-term plans
Compensation structures have
remained the consistent since
shareholder approval of the CEO
Performance Award and Employee
XSP plan, including no further equity
grants and no salary increases in for
NEOs 2025
2025 Compensation Reflected Axon’s Strong 2025 Performance
Our financial and business highlights for 2025 include the following:
Annual revenue grew 33% to $2.8 billion, marking our fourth consecutive year of 30%+ annual growth
Surpassed $1.3 billion in annual recurring revenue, up 35% year over year
Generated annual bookings of $7.4 billion, up 46% year over year
Reached total future contracted bookings of $14.4 billion, an increase of 43% year over year
Achieved a full-year net income margin of 4.5% alongside a 25.5% adjusted EBITDA margin
Introduced major product expansions, including Axon Vehicle Intelligence, Axon Assistant, Axon Body Mini and
Axon 911
Axon Enterprise, Inc. | 2026 Proxy Statement | 36
Table of Contents
Because of our focus on our long-term incentive programs, we made limited adjustments to annual salary and annual cash
incentive bonus programs in 2025:
Annual salaries remained unchanged in 2025 with the exception of Mr. Isner. As discussed within the prior year
proxy statement, Mr. Isner and the Compensation Committee agreed that Mr. Isner would receive a reduced
amount of annual cash compensation during 2025 in exchange for the Company authorizing his use of private air
travel for business purposes in certain circumstances not currently covered by our utilization policy. Mr. Isner’s 
2025 annual base salary was $125,000, compared to $500,000 in 2024.
Annual cash incentive program paid out at 135.9% for our NEOs in 2025 (other than our CEO who does not
receive an annual cash incentive), which aligns with our strong financial performance highlighted above and the
outperformance of key performance indicators: revenue, adjusted EBITDA margin, new market bookings, new
product bookings and new product adoption.
Components of Executive Compensation and Initial 2025 Target Direct Compensation
We utilize various cash and non-cash compensation methods. The principal components of compensation in 2025 for our
NEOs (other than the CEO) consist of the following:
Annual salary;
Annual cash incentive bonus; and
Long-term equity compensation in the form of performance-based XSUs and service-based RSUs.
Each of these components is discussed further below. In addition, we offer benefit plans and retirement programs to our
executives. Any decision to materially increase compensation is based upon the objectives listed above, taking into account
all forms of compensation and individual achievement of performance goals. Decisions regarding the CEO’s compensation
are made by the Compensation Committee and reflect the same considerations used for the other NEOs. With respect to
CEO compensation, the primary component of our CEO’s compensation is the CEO Performance Award, which
encourages long-term shareholder value creation via pre-set metrics and performance hurdles, along with stock price
appreciation. Under the terms of the CEO Employment Agreement (as defined below), Mr. Smith receives a base salary at
the minimum wage rate in the amount of $31,201, and is not entitled to any annual bonus or other short-term incentives.
The table below shows the composition of each NEO’s annualized target total direct compensation at the beginning of
2025. As described below, a significant portion of each NEO’s annualized target compensation for 2025 consisted of equity
awards granted in prior years which were intended to serve as 2025 compensation, and the amounts below for long-term
equity compensation reflect the target annual value of the prior year grants. For details on total compensation earned by our
NEOs during 2025, see “Executive Compensation—2025 Summary Compensation Table.”
2025
Annual Salary (1)
Annual Target
Cash Incentive
Compensation (2)
Long-term Target
Equity
Compensation--
XSUs (3)
Long-term Target
Equity
Compensation--
RSUs (4)
Target Total
Direct
Compensation
Name
$
% Total
$
% Total
$
% Total
$
% Total
$
Patrick Smith
$31,201
0.4%
$
%
$7,143,000
99.6%
$
%
$7,174,201
Joshua Isner
125,000
1.1
425,000
3.6
5,000,000
42.1
6,320,000
53.2
11,870,000
Brittany Bagley
450,000
6.9
600,000
9.2
2,250,000
34.6
3,200,000
49.3
6,500,000
Jeffrey Kunins
350,000
6.6
350,000
6.6
1,518,000
28.6
3,082,000
58.2
5,300,000
Cameron Brooks (5)
400,000
8.4
600,000
12.6
1,500,000
31.6
2,250,000
47.4
4,750,000
(1)Annual salary effective January 1, 2025.
(2)Presented at target levels. For details on the actual total annual cash incentive compensation earned by our NEOs
in 2025, see detail under “2025 Annual Cash Incentive Program.”
Axon Enterprise, Inc. | 2026 Proxy Statement | 37
Table of Contents
(3)Reflects the annual target value of the CEO Performance Award granted to Mr. Smith in 2024 and the value of the
awards granted under the Employee XSP to Mr. Isner, Ms. Bagley, Mr. Kunins and Mr. Brooks in 2024, as
discussed in the prior year proxy statement. The grants had an annual target value of $7,143,000, $5,000,000,
$2,250,000, $1,518,000 and $1,500,000, respectively, prior to the risk multiplier of three and the duration
multiplier of seven, and were granted in lieu of traditional performance-based RSUs. Represents the amount of
annual target compensation that the executives elected to receive over a seven-year period (2024 to 2030) in the
form of XSUs. For the full grant date value of these awards in the year of grant, refer to our prior year proxy
statement.
(4)Reflects the grant date fair value of RSUs vesting in 2025 that were granted in September 2023 for Ms. Bagley
and Messrs. Isner and Kunins, and granted in April 2024 for Mr. Brooks, which were intended to serve as 2025
compensation awards.
(5)The amount for Mr. Brooks' salary and target bonus reflect the initial amounts at the beginning of 2025 in U.S.
dollars. Actual 2025 salary and bonus compensation for Mr. Brooks presented within the Summary Compensation
Table is converted from euros to U.S. dollars utilizing the exchange rate on the respective payout dates.
Annual Salary
Other than with respect to our CEO, salaries for NEOs are reviewed periodically, as well as at the time of a promotion or
other changes in responsibilities. Consistent with our goal for overall compensation, we set salaries at a competitive level to
ensure we can attract and retain our executives. There is no set percentile of market that we use and executive salaries vary
in their positioning to market depending on factors that may include tenure with the Company, results of personal,
department and corporate performance, complexity and scope of the executive’s responsibilities, and the perceived
detrimental effects to the Company that may result from such executive’s departure. The base salaries of our NEOs, other
than the CEO, reflect input from the CEO and are approved by the Compensation Committee after considering
compensation salary trends, total performance, overall level of responsibilities and compensation levels for comparable
positions in the market for executive talent based on salary surveys and compensation data from peer comparator group
companies.
For 2025, as discussed in the prior year proxy statement, Mr. Isner and the Compensation Committee agreed that Mr. Isner
would receive a reduced amount of annual cash compensation during 2025 in exchange for the Company authorizing his
use of private air travel for business purposes in certain circumstances not currently covered by our utilization policy. No
NEOs received salary increases in 2025. Consistent with our prior disclosures and in response to shareholder feedback,
salaries for NEOs have remained consistent year-over-year, as we focus on incentivizing key talent with the performance of
the Company and in alignment with long-term shareholder value creation via our performance-based equity plans.
2025 Annual Cash Incentive Program and 2025 Annual Cash Incentive Payouts
The objective of the annual cash incentive program has been to provide executives with a short-term, competitive cash
compensation opportunity, as well as to align executive rewards with Company performance. Each year, the Compensation
Committee reviews the framework for the annual cash incentive program, including the potential metrics and associated
weightings and goals, and approves these metrics and any additional metrics to the extent used to determine the payouts to
our NEOs. The Compensation Committee ensures the goals that are set at the beginning of the year are viewed as
challenging but achievable to help support execution against our annual financial and operational priorities to drive long-
term shareholder value. For the 2025 annual cash incentive program, the Compensation Committee added “New Product
Adoption” as a bonus metric, and adjusted overall weighting to reflect this new metric.
Payouts to our NEOs (other than our CEO) under the 2025 annual cash incentive program were based on the achievement
of Company-wide annual financial and operational goals. The Compensation Committee believes the criteria for the annual
cash incentive program were challenging but achievable.
Axon Enterprise, Inc. | 2026 Proxy Statement | 38
Table of Contents
2025 Financial and Operational Goals
Metric
Threshold
Target
Maximum
Actual (1)
Weight
Weighted
Payout
($ in millions)
Revenue
$2,500.0
$2,700.0
$2,850.0
$2,776.0
30.0 %
37.6 %
Adjusted EBITDA Margin (2)
24.0 %
25.0 %
26.0 %
26.8 %
25.0
37.5 %
New Market Bookings
$1,000.0
$1,300.0
$2,500.0
$1,185.0
15.0
13.6 %
New Product Bookings
$600.0
$750.0
$1,450.0
$1,476.0
15.0
30.0 %
New Product Adoption
56.0 %
59.7 %
64.7 %
61.2 %
15.0
17.3 %
Actual attainment/plan payout
100 %
135.9 %
(1)Actual achievement in this column excludes the impact of our acquisition of Invictus Apps, Inc. (“Prepared”) in
2025.
(2)For a discussion as to how adjusted EBITDA margin is calculated from our audited financial statements, see
“Reconciliation of Non-GAAP Measures”. For purposes of functioning as a 2025 financial and operational goal
tied to cash incentive payouts, adjusted EBITDA margin further excludes the impact of tariffs that were newly
implemented in 2025. Management considered removal of tariff impacts to be an equitable adjustment necessary
to give effect to the original intent of the Company performance metrics previously approved by the Committee.
The annual financial and operational goals were based on revenue, adjusted EBITDA margin, new market bookings, new
product bookings, and new product adoption. These metrics each had a threshold, target and maximum goal with
corresponding base payouts of 75%, 100% and 150% of target, respectively, except for the New Market Bookings and New
Product Bookings metrics which had a maximum payout of 200% of target. Achievement of the 2025 cash incentive
program metrics was measured after the Company determined its earnings for 2025.
The actual annual cash incentive program payouts to our NEOs for 2025 were as follows:
Annual Target Cash
Incentive
Compensation
Payout %
Cash Payout
Joshua Isner
$425,000
135.9 %
$577,575
Brittany Bagley
$600,000
135.9 %
$815,400
Jeffrey Kunins
$350,000
135.9 %
$475,650
Cameron Brooks (1)
$600,000
135.9 %
$885,876
(1)Mr. Brooks’ cash payout was made in Euros. Amount above was converted from Euros to U.S. dollars based on
the exchange rate on the respective payout date.
For decisions made regarding the 2026 annual cash incentive program, see “Shareholder Engagement and Forward-
Looking Compensation Decisions for 2026”.
Axon Enterprise, Inc. | 2026 Proxy Statement | 39
Table of Contents
Long-Term Performance-Based Equity Compensation
The Compensation Committee believes that our NEOs should be incentivized by compensation structures that encourage
measured risk taking with the aim of long-term, sustained shareholder value creation. As such, our compensation plans
balance operational metrics with stock price performance, alongside the goal of retaining key executive talent.
In alignment with our Compensation Committee, on May 10, 2024 our shareholders approved the following three equity
plans that align with our compensation philosophy to support the Company’s long-term growth strategy and drive strong
alignment with shareholder interest (each described in further detail below):
CEO Performance Award
eXponential Stock Plan
Amended and Restated 2022 Stock Incentive Plan
CEO Performance Award
The Board of Directors granted our CEO a performance-based grant of XSUs (the “CEO Performance Award”), which was
submitted to our shareholders for approval and subsequently approved on May 10, 2024.  The CEO Performance Award is
performance-based and contingent upon the achievement of both stock price and operational performance hurdles, subject
to certain continued service requirements. The Compensation Committee established a notional value for the CEO
Performance Award of $150 million, representing approximately $7 million of annual target long-term incentive value over
the seven-year term of the CEO Employment Agreement (as defined below), with a risk multiplier of three.
Simplified Formula: [($7 million annual value) x (7-year term)] x risk multiplier of 3 → approximately $150 million
The number of shares subject to the CEO Performance Award was calculated by dividing the notional value of the award
determined by the Compensation Committee by a 90-day volume weighted average price per share of Company common
stock as of the day preceding the grant date.
eXponential Stock Plan
On May 10, 2024, our shareholders approved the Axon Enterprise, Inc. 2024 eXponential Stock Plan (the “Employee XSP”
or “XSP 2.0”), which provides for grants of XSU awards to employees and our NEOs (other than our CEO).The XSU
awards are performance-based and contingent upon the achievement of the same stock price and operational performance
hurdles as the CEO Performance Award, subject to certain continued service requirements. The number of shares subject to
each XSU award was calculated by dividing the notional value of the award determined by the Compensation Committee
by a 90-day volume weighted average price per share of Company common stock as of the day preceding the grant date.
Axon Enterprise, Inc. | 2026 Proxy Statement | 40
Table of Contents
The Employee XSP recognizes Axon’s global growth potential and is designed to motivate our employees who are
instrumental to the innovation and development of Axon’s new products and who continue to deliver exceptional value to
Axon. As originally approved, the program includes seven substantially equal tranches that will vest upon certification by
the Compensation Committee upon achievement of three independent vesting conditions, described in the following table:
Operational Goals (1)
(in millions)
Stock Price
Goal
Minimum Service Requirement
Tranche (2)
Revenue
Adj. EBITDA (3)
Employee XSP
CEO Performance
Award
Goal Expiration
1
$1,834
or
$382
and
$247.40
and
June 2025
December 2028
December 2026
2
2,293
or
497
and
309.25
and
December 2025
December 2028
December 2027
3
2,866
or
611
and
386.56
and
June 2026
December 2029
December 2028
4
3,583
or
801
and
483.20
and
December 2026
December 2029
December 2029
5
4,479
or
1,044
and
604.00
and
June 2027
December 2030
December 2030
6
5,599
or
1,356
and
755.00
and
December 2027
December 2030
December 2031
7
6,999
or
1,706
and
943.75
and
June 2028
December 2030
December 2032
(1) Operational goals are measured, as of any date, for the previous four consecutive fiscal quarters, beginning with
the Company’s first full fiscal quarter ending after the fiscal quarter in which the grant date occurred.
(2)Tranches 1 and 2 vested in June 2025 and December 2025, respectively. As of December 31, 2025, for certain
grantees, the shares acquired upon vesting of Tranche 2 remain subject to a holding period requirement under the
plan, which will expire on the earlier of (i) December 31, 2030 and (ii) the date on which the subsequent tranche
vests.
(3)In connection with certain acquisitions which were completed during fiscal year 2024, the adjusted EBITDA goals
were adjusted as required by the terms of the Employee XSP and CEO Performance Award during fiscal year
2025. For a discussion as to how adjusted EBITDA margin is calculated from our audited financial statements, see
“Reconciliation of Non-GAAP Measures”.
The Company intends to continue granting XSUs to employees at all levels of our organization in place of long-term
performance-based RSUs given the strong alignment with shareholder experience requiring meaningful growth in both
stock price and operational performance. Additional XSUs will be subject to operational goals and stock price goals which
are proportionally higher than the goals applicable to the first seven tranches, as well as longer required service periods.
There were no additional awards made under the CEO Performance Award or the Employee XSP to our NEOs during
2025, and no awards vested under the CEO Performance Award in 2025. Refer to the “Stock Vested” table below for
further information on awards held by our NEOs that vested under the Employee XSP during 2025.
Long-Term Service-Based Equity Compensation
On May 10, 2024, our shareholders approved the Amended and Restated 2022 Stock Incentive Plan (the “2022 Plan”). In
addition to the long-term performance-based equity awards described above, the Compensation Committee believes that
service-based equity compensation under the 2022 Plan with multi-year vesting periods ensures that our NEOs have a
continuing stake in our long-term success, given the heightened risk-reward orientation of the XSUs.
In determining the total number of RSUs to award to each NEO (other than our CEO), the Compensation Committee
considered, among other things, the strategic objectives of the Company over the next three years and the practice of peer
comparator companies. As previously issued awards to our NEOs under the Employee XSP and 2022 Plan compensated
for 2025 long-term service-based compensation, no awards were granted to our NEOs under the 2022 Plan in 2025.
Axon Enterprise, Inc. | 2026 Proxy Statement | 41
Table of Contents
Shareholder Engagement and Forward-Looking Compensation Decisions for 2026
Commensurate with the discussion above, Axon’s current executive compensation program reflects enhancements made
over the past five years in response to shareholder input, particularly around aligning pay with performance and ensuring
our compensation design drives long-term shareholder value. Accordingly, our executive compensation program remained
consistent with the prior year.
The following table shows the composition of each NEO’s total target direct compensation for 2026. As described above, a
significant portion of each NEO’s annualized target compensation for 2026 consists of equity awards granted in prior years
which were intended to serve as 2026 compensation, and the amounts below for long-term equity compensation reflect the
target annual value of the prior year grants. Total target direct compensation for each NEO remained consistent with 2025.
2026
Annual Salary
Annual
Target Cash Incentive
Compensation
Long-term Target
Equity
Compensation--
XSUs (1)
Long-term Target
Equity
Compensation--
RSUs (2)
Target Total
Direct
Compensation
Name
$
% Total
$
% Total
$
% Total
$
% Total
$
Patrick Smith
$31,201
0.4%
$
%
$7,143,000
99.6%
$
%
$7,174,201
Joshua Isner (3)
125,000
1.1
425,000
3.6
5,000,000
42.1
6,320,000
53.2
11,870,000
Brittany Bagley
450,000
6.9
600,000
9.2
2,250,000
34.6
3,200,000
49.3
6,500,000
Jeffrey Kunins
350,000
6.6
350,000
6.6
1,518,000
28.6
3,082,000
58.2
5,300,000
Cameron Brooks (4)
400,000
8.4
600,000
12.6
1,500,000
31.6
2,250,000
47.4
4,750,000
(1)Reflects the value of the CEO Performance Award granted in 2024 to Mr. Smith and the value of the awards
granted in 2024 under the Employee XSP to Mr. Isner, Ms. Bagley, Mr. Kunins and Mr. Brooks. The grants had
an annual target value of $7,143,000, $5,000,000, $2,250,000, $1,518,000 and $1,500,000, respectively, prior to
the risk multiplier of three and the duration multiplier of seven, and were granted in lieu of traditional
performance-based RSUs. Represents the amount of annual target compensation that the executives elected to
receive over a seven-year period (2024 to 2030) in the form of XSUs. For the full grant date value of these awards
in the year of grant, refer to our prior year proxy statement.
(2)Reflects the grant date value of RSUs vesting in 2026 that were granted in September 2023 for Ms. Bagley and
Messrs. Isner and Kunins, and granted in April 2024 for Mr. Brooks, which are intended to serve as 2026
compensation awards.
(3)Consistent with 2025, Mr. Isner and the Compensation Committee agreed that Mr. Isner would receive a reduced
amount of annual cash compensation during 2026 in exchange for the Company authorizing his use of private air
travel for business purposes in certain circumstances not currently covered by our utilization policy.
(4)Mr. Brooks received an additional grant of XSUs made in early 2026 (“Tranche 8-9 Grant”) which represents an
annual target value of $1,500,000, prior to the risk multiplier of three and duration multiplier of two. This Tranche
8-9 Grant represents annual target compensation over the two-year period (2031 to 2032) in the form of XSUs,
reflecting our continued alignment of long-term executive incentives with sustained Company performance.
The Compensation Committee is committed to a compensation philosophy that supports the Company’s long-term growth
strategy and drives strong alignment with shareholder interests. Time- and performance-based equity awards are a core
component of this philosophy and reflect the Committee’s belief that long-term equity incentives are essential to retaining
and motivating executive talent to deliver sustained performance. The pay levels disclosed above are intended to remain
relatively consistent over the next several years. As a general matter, a substantial majority of executive compensation is
performance-based (and approximately 100% in the case of the CEO), reinforcing our pay-for-performance philosophy and
aligning compensation outcomes with the creation of long-term shareholder value. The Company has also committed to a
2.5% annual dilution target from stock-based compensation expense, with these performance-based plans specifically
designed to stay within this threshold.
Strong Governance in Determining Executive Compensation
Our Compensation Committee is currently composed of five independent directors: Hadi Partovi (Chair), Erika Ayers
Badan, Adriane Brown, Michael Garnreiter and Graham Smith. The Compensation Committee makes all decisions
regarding compensation for the CEO and each other NEO.
Axon Enterprise, Inc. | 2026 Proxy Statement | 42
Table of Contents
The Compensation Committee generally receives and reviews materials in advance of each Compensation Committee
meeting. Depending on the agenda for the particular meeting, materials may include:
Financial reports;
Reports on levels of achievement of corporate performance objectives;
Schedules setting forth the total compensation of the NEOs, including base salary, cash incentives, equity awards,
perquisites and other compensation and any potential amounts payable to the NEOs pursuant to employment,
severance and change of control agreements;
Summaries that show the NEOs’ total accumulated stock awards and stock option holdings;
Information regarding compensation paid by comparable companies identified in executive compensation surveys;
and
Reports from consultants and advisors to the Compensation Committee, including Semler Brossy.
Our executive management supports the Compensation Committee in carrying out its responsibilities by preliminarily
outlining compensation levels for NEOs, administering our compensation plans, policies and programs, and providing data
to the Compensation Committee for analysis. Periodically, compensation is initially proposed by the CEO for each
executive (excluding the CEO), consisting of annual base salary, annual cash incentive compensation and long-term equity
compensation, which is then provided to the Compensation Committee for review and approval.
Our Compensation Committee has sole authority to engage the services of outside consultants and advisors, as it deems
necessary or appropriate in the discharge of its duties and responsibilities. The Compensation Committee has budgetary
authority to authorize and pay for the services of outside consultants and advisors, and such consultants and advisors report
directly to the Compensation Committee. During 2025, the Compensation Committee continued the use of compensation
consulting firm Semler Brossy.
The Compensation Committee’s compensation philosophy is to generally set executive and director compensation at
approximately the 50% benchmark to peers and engage a compensation consulting firm to provide research, data analyses,
benchmarking and design expertise in reviewing and structuring compensation programs for the Company’s NEOs
generally every three years, which began in 2018. Compensation generally stays flat in the interim years between
compensation studies although adjustments may be made if appropriate based on individual performance, Company
performance, relative shareholder returns and other relevant considerations. The Compensation Committee also considers
the results of the Company’s say-on-pay vote for the prior year to ensure that its decisions and the Company’s executive
compensation programs for the Company’s NEOs are aligned with long-term shareholder interests. For more detail
regarding how the results of the most recent shareholder advisory vote on executive compensation were considered in
making this year’s compensation decisions, see “Overview and Summary; Consideration of Prior Year Say-on-Pay Vote”
in Proposal No. 2.
Peer Comparator Group
Executive compensation is reviewed every three years, the latest of which was performed by Semler Brossy encompassing
fiscal years 2023 - 2025. The scope of Semler Brossy’s review in 2023 included determining an appropriate comparator
group to which to compare the Company’s executive compensation, based primarily on the following criteria: technology
industry sector, revenue and revenue growth, valuation multiple and market capitalization. Semler Brossy selected public
technology companies with revenues between $435 million and $4 billion and three-month average market capitalization
between $4 billion and $65 billion. We focused on including companies with similar revenue growth profiles.
Axon Enterprise, Inc. | 2026 Proxy Statement | 43
Table of Contents
Based on Semler Brossy’s prior analysis, the Compensation Committee selected the following comparator group when
reviewing executive compensation:
Alarm.com Holdings, Inc.
Fair Isaac Corporation
Procore Technologies
ANSYS
HEICO Corporation
PTC Inc.
Aspen Technology, Inc.
HubSpot
Samsara
Crowdstrike
MongoDB, Inc.
Tyler Technologies Inc.
Datadog
Palantir Technologies
Zscaler
Dynatrace, Inc.
Paycom Software, Inc.
Elastic N.V.
Paylocity Holding Corporation
In addition to the comparator group, to supplement the executive compensation information where publicly disclosed
information was limited, Semler Brossy provided executive compensation information for the NEOs using a survey sample
of technology companies with over $1 billion in revenue.
Compensation Policies and Practices
The Compensation Committee assists the Board of Directors in addressing matters relating to the fair and competitive
compensation of our NEOs and non-employee directors, together with matters relating to our other compensation practices
and policies. The most important policies applicable to our NEOs are described below.
Insider Trading Policy
We have adopted insider trading policies and procedures governing the purchase, sale, and other dispositions of securities
of Axon by the Company, directors, officers, and employees that we believe are reasonably designed to promote
compliance with insider trading laws, rules and regulations. Our insider trading policy states, among other things, that the
Company and our directors, officers, and employees are prohibited from trading in such securities while in possession of
material, nonpublic information. The foregoing summary of our insider trading policies and procedures does not purport to
be complete and is qualified by reference to our Insider Trading Policy filed as an exhibit to our 2024 Annual Report.
NEO Stock Ownership Guidelines
The Board adopted stock ownership guidelines in December 2018. NEOs are required to own at least 50,000 shares of the
Company’s stock. For purposes of these guidelines, stock ownership includes shares for which the executive has direct or
indirect ownership or control, including Axon common stock plus vested and unvested Axon stock options and RSUs,
including unvested performance-based RSUs and XSUs. Executives are expected to meet their ownership guidelines once
they have received enough grants to add up to the required minimum.
Policy Regarding Hedging and Pledging Transactions
The Company’s Insider Trading Policy, which applies to all employees and directors, prohibits hedging and similar
transactions designed to decrease the risks associated with holding Company securities. Our pledging policy limits pledges
to 25% of a party’s total stock holdings at the time such loan(s) was originated. Any pledges in existence prior to the
adoption of such pledging policy are not subject to the 25% limitation, and any pledging arrangements must comply with
all applicable insider trading policies and pre-clearance procedures.
Clawback Policy
In accordance with SEC rules and NASDAQ Listing Standards, we adopted an incentive compensation recovery policy
(the “Clawback Policy”), effective as of December 1, 2023. Pursuant to the Clawback Policy, Axon is required to recover
or “clawback” any erroneously awarded incentive-based compensation received by its executive officers on or after
October 2, 2023, in the event that it is required to prepare an accounting restatement due to material noncompliance with
any financial reporting requirement under the securities laws, including any required accounting restatement to correct an
error in previously issued financial statements that is material to the previously issued financial statements, or that would
result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
Axon Enterprise, Inc. | 2026 Proxy Statement | 44
Table of Contents
Equity Grant Practices
The Company does not have a formal policy relating to the timing of equity grants, but in practice seeks to avoid granting
awards within four days of the release of material, nonpublic information.
Employment Agreements and Other Arrangements with NEOs
CEO Employment Agreement with Patrick Smith
On December 8, 2023, the Company entered into an employment agreement (the “CEO Employment Agreement”) with
Mr. Smith. Under the CEO Employment Agreement, Mr. Smith will continue to serve as the Company’s CEO and remain a
member of the Board. The CEO Employment Agreement provides the specific terms and conditions of Mr. Smith’s
employment through December 31, 2030 and provides for at-will employment for an indefinite period thereafter.
The CEO Employment Agreement generally provides for compensation opportunities to Mr. Smith in a lesser amount than
the Compensation Committee was otherwise willing to provide so that the Company could instead provide enhanced
compensation opportunities to other employees of the Company.
In particular, Mr. Smith will receive a base salary at the minimum wage rate (equating to $31,201 per year), and will not be
eligible for an increase in base salary prior to January 1, 2031. Mr. Smith will not be entitled to any annual bonus or other
short-term incentives.
Pursuant to the CEO Employment Agreement, Mr. Smith agreed that, if he terminates his employment for any reason on or
before December 31, 2030, Mr. Smith will promptly pay to the Company $30 million. In addition, Mr. Smith will be
subject to restrictive covenants related to competition, solicitation of Company employees and customers and
disparagement of the Company.
Employment Agreements with our NEOs
Each of our other NEOs is party to an employment agreement with the Company or an affiliate, which are intended to
ensure each executive’s continued employment and stability within our leadership team. The employment agreements with
each of Messrs. Isner and Kunins and Ms. Bagley are substantially similar and describe the terms and conditions of each
executive’s employment, including compensation levels, benefits and equity incentive eligibility, and also provide that the
executive may be terminated by the Company with or without cause or, solely in connection with a Change in Control (as
defined in the 2019 Stock Incentive Plan or 2022 Stock Incentive Plan), by the executive for good reason. The termination-
related benefits provided under these employment agreements are described in “Potential Payments Upon Termination or
Change of Control”. The employment agreement with Mr. Brooks contains similar terms and conditions as well as includes
certain statutory requirements under Greek law. Each of the employment agreements contains non-compete, non-solicit,
and non-disparagement covenants.
Perquisites and Other Personal Benefits
We have a Deferred Compensation Plan for certain executives, key employees and non-employee directors through which
participants may elect to postpone the receipt and taxation of a portion of their compensation received from us. The
Deferred Compensation Plan allows eligible participants to defer up to 80% of their base salary and up to 100% of other
types of compensation. The plan also allows for matching and discretionary employer contributions. Employee deferrals
are deemed 100% vested upon contribution. Distributions from the plan generally commence upon retirement, death,
separation of service, a specified date or upon the occurrence of an unforeseeable emergency. Distributions can be paid in a
variety of forms from lump sum to installments over a period of years. Participants in the plan are entitled to select from a
wide variety of investments available under the plan and are allocated gains or losses based upon the performance of the
investments selected by the participant. All gains or losses are allocated fully to plan participants and we do not guarantee a
rate of return on deferred balances. Assets related to this plan consist of corporate-owned life insurance contracts.
Participants have no rights or claims with respect to any plan assets and any such assets are subject to the claims of our
general creditors.
Axon Enterprise, Inc. | 2026 Proxy Statement | 45
Table of Contents
We provide, subject to the terms of our utilization policy, private air transportation coordinated by the Company for
business use, with incidental personal use permitted under certain circumstances as approved by the Chair of the
Compensation Committee. As described above, the Compensation Committee also permits Mr. Isner to use private air
travel for business purposes under certain circumstances not currently covered by our utilization policy. We also provide
our NEOs with the option of utilizing concierge medical services. Other than as described above, we do not provide our
NEOs with other significant perquisites or other benefits, except for Company matching contributions to our defined
contribution benefit plans and health care benefits that are widely available to employees. The Compensation Committee
periodically reviews the levels of perquisites and other benefits that could be provided to the NEOs.
COMPENSATION COMMITTEE REPORT
The Compensation Committee has reviewed and discussed with management the Compensation Discussion and Analysis
included in this proxy statement. Based on these reviews and discussions, the Compensation Committee recommended to
the Board of Directors that the Compensation Discussion and Analysis be included in this proxy statement.
The Compensation Committee:
Hadi Partovi, Chair
Erika Ayers Badan
Adriane Brown
Michael Garnreiter
Graham Smith
The foregoing Compensation Committee Report does not constitute soliciting material and will not be deemed to be filed or
incorporated by reference by any general statement incorporating by reference this proxy statement into any other
Company filing under the Securities Act or Exchange Act, except to the extent the Company specifically incorporates this
Report by express reference therein.
Axon Enterprise, Inc. | 2026 Proxy Statement | 46
Table of Contents
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
No member of the Compensation Committee is, or was during or prior to 2025, an officer or employee of the Company or
any of its subsidiaries. None of the Company’s executive officers serves as a director or member of the compensation
committee of another entity in a case where an executive officer of such other entity serves as a director or member of the
Compensation Committee.
Axon Enterprise, Inc. | 2026 Proxy Statement | 47
Table of Contents
2025 SUMMARY COMPENSATION TABLE
The following Summary Compensation Table provides information concerning the 2025 compensation of our CEO and
other NEOs as of the end of the fiscal year. For a complete understanding of the table, please read the footnotes and
narrative disclosures that follow the table.
As discussed above, the CEO Performance Award and Employee XSP are high-risk, high-reward compensation plans that
are 100% performance-based, with vesting of the underlying XSUs entirely tied to the achievement of three independent
vesting conditions: (i) stock price goals; (ii) operational goals; and (iii) minimum service requirements. Although these
grants are intended to compensate our NEOs over a seven-year term (2024 to 2030), to comply with SEC rules, the entire
grant date fair value has been included in the table(s) below with respect to compensation during 2024. For the annual
amount of target compensation under these plans, calculated prior to the risk multiplier of three and the duration multiplier
of seven, refer to “Components of Executive Compensation and Initial 2025 Target Direct Compensation” above.
Name and Principal
Position
Year
Salary
($)
Bonus
($)
Stock
Awards (1)
($)
Non-Equity
Incentive Plan
Compensation (2)
($)
All Other
Compensation (3)
($)
Total ($)
Patrick Smith
2025
$31,201
(4)
$
$
$
$8,800
$40,001
Chief Executive Officer
2024
31,201
(4)
164,463,091
31,429
164,525,721
2023
31,201
(4)
8,857
40,058
Joshua Isner
2025
125,000
(5)
577,575
25,766
728,341
President
2024
500,000
116,855,483
658,500
54,238
118,068,221
2023
425,000
29,955,689
1,066,500
43,608
31,490,797
Brittany Bagley
2025
450,000
815,400
29,872
1,295,272
Chief Operating Officer and
Chief Financial Officer
2024
450,000
52,152,312
790,200
27,802
53,420,314
2023
450,000
8,932,642
892,563
24,769
10,299,974
Jeffrey Kunins
2025
350,000
475,650
38,561
864,211
Chief Product Officer and
Chief Technology Officer
2024
350,000
35,190,696
460,950
30,193
36,031,839
2023
325,000
10,480,425
521,304
33,313
11,360,042
Cameron Brooks
2025
418,661
(6)
885,876
(7)
6,844
1,311,381
Chief Revenue Officer
2024
304,342
300,000
37,018,911
576,393
16,742
38,216,388
(1)No awards were granted to our NEOs in 2025.
(2)In 2025, Ms. Bagley and Messrs. Isner, Kunins and Brooks received non-equity, cash-based incentive
compensation payments as a result of exceeding target metrics around revenue and other goals during 2025. This
incentive compensation was paid in February and March 2026.
(3)All other compensation consists of matching contributions made to our 401(k) plan, contributions to health
savings accounts, employer-paid life insurance premiums, costs associated with guest travel to and attendance at
business events, costs of supplemental medical services, and payments made for taxes required to gross-up other
earnings. Tax reimbursements or “gross-ups” for all applicable perquisites were $7,889, $6,680, $3,203 and
$7,417 for Messrs. Isner, Kunins, and Brooks, and Ms. Bagley, respectively.
(4)The amounts paid to Mr. Smith for 2025, 2024 and 2023 are consistent with minimum wage requirements.
(5)As discussed in the prior year proxy statement, Mr. Isner and the Compensation Committee agreed that Mr. Isner
would receive a reduction in annual cash compensation of $375,000 during 2025 in exchange for the Company
authorizing his use of private air travel for business purposes in certain circumstances not currently covered by our
utilization policy.
(6)Mr. Brooks’ salary was converted from euros to U.S. dollars utilizing the average exchange rate for 2025.
(7)Mr. Brooks’ bonus was converted from euros to U.S. dollars utilizing the exchange rates on the respective payout
dates.
Axon Enterprise, Inc. | 2026 Proxy Statement | 48
Table of Contents
2025 GRANTS OF PLAN-BASED AWARDS
The following table shows information about awards made under various compensation plans during 2025:
Name
Grant Date (1)
Estimated future payouts under
non-equity incentive
plan awards
All other
stock
awards:
number of
shares of
stock or
units (1) (#)
Grant date
fair
value of stock
awards (1)
($)
Threshold
($)
Target
($)
Maximum
($)
Patrick Smith
Joshua Isner
318,750
425,000
701,250
(2)
Brittany Bagley
450,000
600,000
990,000
(2)
Jeffrey Kunins
262,500
350,000
577,500
(2)
Cameron Brooks
450,000
600,000
990,000
(2)
(1)No stock awards were granted to our NEOs in 2025.
(2)Payouts under the annual cash incentive program are based on the achievement of annual financial and operational
goals, including goals related to revenue, adjusted EBITDA margin, new market bookings, new product bookings,
and new product adoption. Actual awards earned in 2025 are included in the non-equity incentive plan
compensation column in the 2025 Summary Compensation Table. See further discussion under “Executive
Compensation—Compensation Discussion and Analysis—2025 Annual Cash Incentive Program and 2025 Annual
Cash Incentive Payouts.”
Axon Enterprise, Inc. | 2026 Proxy Statement | 49
Table of Contents
OUTSTANDING EQUITY AWARDS AT FISCAL 2025 YEAR-END
The following table includes certain information with respect to all outstanding equity awards previously awarded to the
NEOs as of December 31, 2025. The value of the stock awards reflected below is based on the closing market price of a
share of the Company’s common stock as of December 31, 2025 ($567.93).
Option Awards
Stock Awards
Name
Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#)
Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options (#)
Option
Exercise
Price
($)
Option
Expiration
Date
Number of
Shares or
Units
of Stock
That
Have Not
Vested
(#)
Market
Value
of Shares
or Units
of Stock
That Have
Not Vested
($)
Equity
Incentive
Plan Awards:
Number of
Unearned
Shares,
Units or
Other
Rights That
Have
Not Vested
(#)
Equity
Incentive
Plan Awards:
Market or
Payout
Value of
Unearned
Shares, Units or
Other Rights
That Have Not
Vested
($)
Patrick Smith
20,931
(1)
$28.58
2/26/2028
679,102
(5)
$385,682,399
Joshua Isner
32,480
(2)
18,446,366
339,550
(6)
192,840,632
Brittany Bagley
16,446
(2)
9,340,177
152,798
(6)
86,778,568
Jeffrey Kunins
14,133
(2)
8,026,555
103,087
(6)
58,546,200
1,706
(3)
968,889
Cameron Brooks
11,916
(4)
6,767,454
94,857
(6)
53,872,136
(1)These option awards were granted to Mr. Smith pursuant to the 2018 CEO Performance Award.
(2)These stock awards vest at annual intervals over a three-year period and become fully vested in August 2026.
(3)This stock award vests one-third in December 2024, one-third in August 2025 and one-third in August 2026.
(4)This stock award vests one-third in May 2025 and the remaining two-thirds in eight substantially equal quarterly
installments until fully vested in May 2027.
(5)This stock award granted to Mr. Smith pursuant to the CEO Performance Award vests upon the achievement of
three independent vesting conditions: (1) stock price goals; (2) operational goals; and (3) minimum service
conditions. The stock price goals and operational goals applicable to the CEO Performance Award are identical to
those under the Employee XSP, but Mr. Smith is subject to a longer minimum required service period.
(6)These stock awards granted pursuant to the Employee XSP vest upon the achievement of three independent
vesting conditions: (1) stock price goals; (2) operational goals; and (3) minimum service conditions.
Axon Enterprise, Inc. | 2026 Proxy Statement | 50
Table of Contents
2025 OPTION EXERCISES AND STOCK VESTED
Option Exercises
No options were exercised by Mr. Smith in 2025 related to the 2018 CEO Performance Award. None of our other NEOs
hold options.
Stock Vested
The following table provides information related to restricted stock unit awards which vested during the year ended
December 31, 2025:
Restricted Stock Unit Awards
Name
Number of
Shares
Acquired upon
Vesting (#)
Value Realized
on
Vesting ($)
Patrick Smith
$
Joshua Isner
33,393
24,668,870
Brittany Bagley
33,574
23,756,700
Jeffrey Kunins
15,977
11,542,146
Cameron Brooks
11,799
8,229,611
The following table provides information related to the XSU awards under the CEO Performance Award and Employee
XSP which vested during the year ended December 31, 2025:
XSU Awards
Name
Number of
Shares
Acquired upon
Vesting (#) (1)
Value Realized
on
Vesting ($)
Patrick Smith
$
Joshua Isner
135,822
87,726,072
Brittany Bagley
61,120
39,476,797
Jeffrey Kunins
41,236
26,633,920
Cameron Brooks
15,810
11,246,285
(1) For Messrs. Isner and Kunins and Ms. Bagley, reflects Tranches 1 and 2 which vested in June 2025 and December
2025, respectively. For Mr. Brooks, reflects Tranche 1 which vested in October 2025. The latest vested tranche
remains subject to a holding period requirement under the Employee XSP, which will expire on the earlier of (i)
December 31, 2030, and (ii) the date on which the subsequent tranche vests. No XSUs have vested for Mr. Smith
under the CEO Performance Award. The performance metrics for Tranche 3 of the Employee XSP and CEO
Performance Plans were certified as achieved by the Compensation Committee on November 13, 2025. However,
due to minimum service requirements, Tranche 3 is not yet considered vested as of December 31, 2025.
Axon Enterprise, Inc. | 2026 Proxy Statement | 51
Table of Contents
2025 NONQUALIFIED DEFERRED COMPENSATION
On July 1, 2013, the Company adopted our Deferred Compensation Plan. The Deferred Compensation Plan allows eligible
executives, key employees and non-employee directors to elect to defer the receipt and taxation of a portion of their
compensation. Compensation, as defined in the Deferred Compensation Plan, is comprised of base salary, bonus,
commission, director fees and such other cash or equity-based compensation approved by the Compensation Committee.
Participants may elect to defer up to 80% of their base salary and up to 100% of other types of compensation. Participants
are 100% vested at all times in amounts deferred pursuant to the Deferred Compensation Plan. All gains or losses are
allocated fully to plan participants, and the Company does not guarantee a rate of return on deferred balances. There were
no above-market returns for participants in the Deferred Compensation Plan.
The following table provides information on NEO participation in the Deferred Compensation Plan:
Name
Executive
Contributions in
Last FY (1)
($)
Registrant
Contributions in
Last FY (2)
($)
Aggregate
Earnings in Last
FY (2)(3)
($)
Aggregate
Withdrawals/
Distributions in
Last FY
($)
Aggregate
Balance at
Last FYE (4)
($)
Joshua Isner
10,324
(135,100)
29,690
Brittany Bagley
407,700
51,138
853,938
(1)Ms. Bagley elected to contribute 50% of her 2025 bonus (as reflected in the Summary Compensation Table) to the
Deferred Compensation Plan. Such amount is reflected above, although the amount was deferred into the Deferred
Compensation Plan in the first quarter of 2026.
(2)The Company does not make discretionary payments to the Deferred Compensation Plan but does make a
restorative 401(k) match contribution to participants as their eligible wages for 401(k) purposes is net of
contributions made to the Deferred Compensation Plan.
(3)Aggregate earnings reflected represent deemed investment earnings from voluntary deferrals and Company
contributions, as applicable. No amounts included in aggregate earnings are reported in the Summary
Compensation Table because the Deferred Compensation Plan does not provide for above-market or preferential
earnings.
(4)Of the amount reflected in this column for Mr. Isner, the aggregate balance includes $436,508 from compensation
previously reported in the Summary Compensation Table for 2021 and previous years and $735,252 has been
reported as aggregate withdrawals and distributions for 2025 and previous years. No withdrawals or distributions
were made in 2024.  Mr. Isner has not made any executive contributions since 2021. Of the amount reflected in
this column for Ms. Bagley, $395,100 was previously reported as compensation in the Summary Compensation
Table for 2024. Although Ms. Bagley deferred amounts into the Deferred Compensation Plan in the first quarter
of 2025, the contribution was an election for 50% of her 2024 bonus and considered a 2024 contribution for
reporting purposes.
Axon Enterprise, Inc. | 2026 Proxy Statement | 52
Table of Contents
POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL
Pursuant to the employment agreements with our NEOs (other than our CEO), the Company may terminate each of the
NEOs with or without cause. The conditions or events triggering the payment of cash severance benefits include the
executive’s termination without cause, termination in certain circumstances in connection with a change in control of the
Company (i.e., double-trigger), and death or disability. Cash severance benefits are payable in substantially equal
installments in accordance with the Company’s standard payroll practices and applicable law, and any bonuses are paid at
the time such bonuses are paid to other employees of the Company generally. Conditions to the payment of severance
benefits include the execution (and non-revocation) of a release in favor of the Company and continued compliance with
certain restrictive covenants relating to assignment of inventions, nondisclosure of Company confidential information, and
(if applicable) non-competition with the Company for a period of 12 months after termination of employment.
The severance benefit amounts with respect to the above triggering events were determined based on competitive practices.
The Company agreed to pay these variable amounts of compensation as severance benefits in order to attract and retain
executive officers.
The table below depicts the severance benefits payable to each of the NEOs (other than our CEO) under the conditions
indicated, other than with respect to awards under the CEO Performance Award and the Employee XSP, which are
described below:
Termination for
Cause
Termination without Cause
Termination By Executive Within
36 Months Following a Change
in Control For Good Reason or by
the Company Without Cause
Six Months Prior to Change in
Control at the Request of a Third-
Party Purchaser
(“Change in Control”)
Death or Disability
Earned but
unpaid salary and
benefits
12 months’ salary
continuation (1);
annual target bonus for the
year in which termination
occurs;
time-based RSUs vesting
during notice and severance
period continue to
vest
36 months’ salary continuation (3);
pro rata portion of annual target
bonus for the year in which
termination
occurs; 12 months’ healthcare
benefits (2);
time-based RSUs vest
18 months’ salary
continuation (3);
pro rata portion of annual
target bonus for the year in
which death or disability
occurs;
time-based RSUs vest
(1)The payment of 12 months’ salary includes an 11-month notice period and a cash payment equal to one month’s
base salary. For Mr. Brooks, benefits payable are the higher of either 12 months' salary or a statutory severance
payment.
(2)Healthcare benefits include a lump sum payment equal to 12 months of COBRA premiums (including medical and
dental coverage) for Messrs. Isner and Kunins and Ms. Bagley, and 12 months of healthcare benefits for Mr.
Brooks.
(3)Mr. Brooks would receive a statutory severance payment in lieu of salary payment.
Axon Enterprise, Inc. | 2026 Proxy Statement | 53
Table of Contents
Additional accelerated vesting conditions pursuant to the CEO Performance Award and the Employee XSP are as follows:
CEO Performance Award (Patrick
Smith)
Employee XSP
(all other NEOs)
Termination for Cause
Any tranches of the CEO Performance
Award that are unvested as of the date
of termination are forfeited
Any tranches of the 2024 Employee
XSP that are unvested as of the date of
termination are forfeited
Termination without Cause
Operational goals are disregarded and
all tranches for which stock price goals
have been attained as of the date of
termination vest; next unattained
tranche will partially vest on a prorated
basis by comparing the ninety-day
volume-weighted average price to the
stock price goal
Operational goals are disregarded and
all tranches for which stock price goals
have been attained as of the date of
termination vest; next unattained
tranche will partially vest on a prorated
basis by comparing the ninety-day
volume-weighted average price to the
stock price goal
Change in Control Without
Termination
Stock price goals are compared against
the greater of closing price immediately
prior to Closing Date and per share
stock price received by stockholders in
such change in control; tranches
qualifying as “CIC Units” for which
the minimum service date has occurred
will vest; CIC Units for which the
minimum service date has not yet
occurred remain outstanding and
eligible to vest based on attainment of
minimum service requirements;
operational goals are disregarded
Stock price goals are compared against
the greater of closing price immediately
prior to Closing Date and per share
stock price received by stockholders in
such change in control; tranches
qualifying as “CIC Units” for which
the minimum service date has occurred
will vest; CIC Units for which the
minimum service date has not yet
occurred remain outstanding and
eligible to vest based on attainment of
minimum service requirements;
operational goals are disregarded
Termination By Executive Within 24
Months Following a Change
in Control For Good Reason or By the
Company Without Cause
Any “CIC Unit” tranches of the CEO
Performance Award that are unvested
as of the date of termination
immediately vest
Any “CIC Unit” tranches of the 2024
Employee XSP that are unvested as of
the date of termination immediately
vest
Death or Disability
Minimum service date requirements
are disregarded and any tranches for
which stock price goals and operational
goals have been achieved as of the date
of termination immediately vest
Minimum service date requirements
are disregarded and any tranches for
which stock price goals and operational
goals have been achieved as of the date
of termination immediately vest
Axon Enterprise, Inc. | 2026 Proxy Statement | 54
Table of Contents
The table below reflects the cash severance, equity acceleration and continuation of employee benefits that would be
provided to each of the NEOs assuming the notice of intent to terminate such executive’s employment occurred on
December 31, 2025. The following table excludes the deferred compensation amounts that would also be payable to Mr.
Isner or Ms. Bagley (see “Executive Compensation—2025 Nonqualified Deferred Compensation”).
Voluntary
Termination
By Executive
Termination
for Cause
Termination
without
Cause (1)
Change in
Control (2)
Death or
Disability
Patrick Smith
$
$
$330,585,238
$
$165,293,187
Joshua Isner
$
$
$173,268,872
$19,275,160
$57,626,993
Brittany Bagley
$
$
$79,813,372
$11,318,773
$27,971,118
Jeffrey Kunins
$
$
$56,532,630
$10,429,066
$21,580,024
Cameron Brooks
$
$
$50,405,367
$7,414,005
$25,347,545
(1)Severance amounts based on annual bonus are calculated based on 2025 target bonus amounts.
(2)This includes a termination within 24 months following a Change in Control (a) by the NEO for Good Reason or
(b) by the Company without Cause. Assumes that the relevant Change in Control and termination occur on
December 31, 2025, and that no tranches of Employee XSP and CEO Performance Award are determined to be
"CIC Units" as defined in the applicable plans.
The value of time-based RSUs reflected in amounts above is equal to the most available closing market price of a share of
the Company’s common stock as of December 31, 2025 ($567.93), multiplied by the number of units that would vest.
Axon Enterprise, Inc. | 2026 Proxy Statement | 55
Table of Contents
PAY VERSUS PERFORMANCE
As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of
Regulation S-K under the Exchange Act, we are providing the following information about the relationship between
executive compensation actually paid and the financial performance of our Company. The following table sets forth the
compensation for our CEO or principal executive officer (“PEO”) and the average compensation for our other NEOs. For
further information concerning our compensation philosophy and how we align executive compensation with our
performance, see “Executive Compensation—Compensation Discussion and Analysis.”
Value of Initial $100
Investment Based on
Year
Summary
Compensation
Table Total for
PEO (1)
Compensation
Actually Paid
to PEO (2) (3)
Average Summary
Compensation
Table Total for
Non-PEO NEOs (1)
Average
Compensation
Actually Paid to
Non-PEO NEOs (2) (3)
Total
Shareholder
Return
Peer Group
Total
Shareholder
Return (5)
Net Income (loss)
(in thousands)
Adjusted
EBITDA (6)
(in thousands)
2025
40,001
(12,580,422)
1,049,801
4,583,563
$463.27
$187.14
$124,656
$710,155
2024
164,525,721
385,171,518
61,434,191
151,439,028
484.86
154.48
377,034
521,375
2023
40,058
43,533,121
17,716,938
28,506,155
210.78
119.22
175,783
331,396
2022
33,203
13,687,307
4,305,869
2,091,584
135.40
82.43
146,930
232,033
2021
33,115
253,610,579
5,634,227
30,194,861
128.13
122.18
(56,339)
183,086
(1)For each year presented, Patrick Smith was our PEO; reflects amounts reported in the Summary Compensation
Table for the respective years. Our non-PEO NEOs for 2025 were Ms. Bagley and Messrs. Isner, Kunins and
Brooks. Our non-PEO NEOs for 2024 were Ms. Bagley and Messrs. Isner, Kunins and Brooks. Our non-PEO
NEOs for 2023 were Ms. Bagley and Messrs. Isner and Kunins. Our non-PEO NEOs for 2022 were Ms. Bagley
and Messrs. Isner, Kunins, Larson, Ahsan and Zito. Our non-PEO NEOs for 2021 were Messrs. Larson, Ahsan,
Isner and Kunins. Average compensation for the non-PEO NEOs reflects amounts reported in the Summary
Compensation Table for the respective years.
(2)Amounts shown for compensation actually paid (“CAP”) are computed in accordance with Item 402(v) of
Regulation S-K under the Exchange Act and do not reflect the actual amount of compensation earned by or paid to
the NEOs during the applicable year. These amounts reflect total compensation as reported in the Summary
Compensation Table with certain adjustments as required by Item 402(v) of Regulation S-K as described in Note
(3) below.
(3)CAP reflects the exclusions and inclusions of equity awards for the PEO and the other NEOs as set forth below
and calculated in accordance with ASC Topic 718. The valuation methodologies and assumptions used to
calculate CAP are based on the grant date fair value of these awards as disclosed in the Company’s consolidated
financial statements filed with the SEC on Annual Report on Form 10-K for each of the years reflected in the table
below:
Axon Enterprise, Inc. | 2026 Proxy Statement | 56
Table of Contents
Summary Compensation Table Total to CAP Reconciliation for the PEO and the other NEOs for 2025:
Calculation of Compensation Actually Paid
Calculation for PEO
Calculation for Average
of Non-PEOs
Summary Compensation Table Total
$40,001
$1,049,801
Less grant date fair value of stock and option awards reflected in Summary
Compensation Table
Add year-end fair value of awards granted during the fiscal year that are outstanding
and unvested as of the end of the fiscal year
Add change in fair value (whether positive or negative) as of fiscal year-end for
outstanding and unvested awards granted in prior fiscal years
(12,620,423)
(3,431,577)
Add fair value as of vesting date of awards granted during the fiscal year which
vested in the same fiscal year
Add change in fair value (whether positive or negative) as of vesting date of awards
granted in prior fiscal years for which all applicable vesting conditions were
satisfied during the fiscal year (4)
6,965,339
Subtract the fair value as of prior fiscal year-end for awards granted in prior years
that failed to meet the applicable vesting conditions during the fiscal year
Compensation Actually Paid
$(12,580,422)
$4,583,563
For purposes of the above adjustments, the fair value of the equity awards on the applicable date was determined
in accordance with FASB ASC Topic 718, using valuation methodologies that are generally consistent with those
used to determine the grant date fair value for accounting purposes.
(4)Certain of these awards remain subject to a holding period.
(5)Total Shareholder Return (“TSR”) shown in this table utilizes the NASDAQ Composite Index that we use in the
stock performance graph required by Item 201(e) of Regulation S-K included in the Company’s consolidated
financial statements filed with the SEC in our 2025 Annual Report. The comparison assumes $100 was invested
for the period starting December 31, 2020 through December 31 of the applicable fiscal year in each of the
Company’s common stock and the NASDAQ Composite Index. All dollar values assume reinvestment of the pre-
tax value of dividends paid by companies included in the NASDAQ Composite Index. The historical stock price
performance of our common stock shown is not necessarily indicative of future stock price performance.
(6)Pursuant to Item 402(v) of Regulation S-K under the Exchange Act, we determined adjusted EBITDA to be the
most important financial performance measure used to link Company performance to CAP for our PEO and our
other NEOs in 2025, 2024, and 2023. This performance measure may not have been the most important financial
performance measure for years 2022 and 2021 and we may determine a different financial performance measure
to be the most important such measure in future years. Adjusted EBITDA is defined as earnings before interest
expense; investment interest income; income taxes; depreciation; amortization; noncash stock-based compensation
expense; fair value adjustments related to strategic investments, marketable securities, and mark-to-market on our
non-qualified deferred compensation liabilities; debt inducement expense associated with the early repurchase of a
portion of our 2027 Notes; non-recurring severance costs, including employee cash payments, equity, and related
benefits; transaction and integration costs related to strategic investments and acquisitions, including the change in
fair value of contingent consideration arrangements; payroll taxes related to Employee XSP vesting and 2018
CEO Performance Award option exercises; costs (or subsequent recoveries of prior costs) related to certain legal
or regulatory matters we consider outside of our core operating activities; losses incurred as a result of the
disposal, abandonment, and impairment of property, equipment and intangible assets; inventory step-up
amortization related to acquisitions; and loss recoveries. For a reconciliation of adjusted EBITDA to net income,
see “Reconciliation of Non-GAAP Measures.”
Axon Enterprise, Inc. | 2026 Proxy Statement | 57
Table of Contents
Pay Versus Performance Relationship Descriptions:
Figure 1: Relationship between Axon’s CAP for PEO and NEOs (Average) vs. cumulative TSR of Axon and the peer
group
1649267447898
Figure 2: Relationship between Axon’s CAP for PEO and NEOs (Average) vs. Axon’s net income
1649267447902
Axon Enterprise, Inc. | 2026 Proxy Statement | 58
Table of Contents
Figure 3: Relationship between Axon’s CAP for PEO and NEOs (Average) vs. Adjusted EBITDA (1)
1649267447906
(1)Adjusted EBITDA is a non-GAAP financial measure; see “Reconciliation of Non-GAAP Measures” for
definitions of non-GAAP financial measures and a reconciliation of such measures to the most directly
comparable GAAP measures.
Set forth below is a list of the three most important financial performance measures used to link executive compensation
actually paid to our NEOs during 2025 to Company performance:
Adjusted EBITDA;
Revenue; and
Company stock price.
Axon Enterprise, Inc. | 2026 Proxy Statement | 59
Table of Contents
PAY RATIO OF CEO COMPENSATION
TO MEDIAN EMPLOYEE COMPENSATION
The Company designs its compensation programs to be fair, equitable, globally compliant and aligned with our business
objectives. Our CEO, Patrick Smith, has agreed to performance-based compensation arrangements in the form of the CEO
Performance Award, and as described elsewhere in this proxy statement, Mr. Smith does not receive significant
compensation or benefits other than these performance-based awards. We are providing a ratio of (i) Mr. Smith’s 2025
annual total compensation to (ii) the median of the 2025 annual total compensation of all Axon employees other than Mr.
Smith, calculated pursuant to the disclosure requirements of the Summary Compensation Table above as if the median
compensated employee was a named executive officer.
Mr. Smith’s annual total compensation, as reported in the Summary Compensation Table above, was $40,001 for 2025, and
the median 2025 annual total compensation of all other employees was $135,696. Consequently, the applicable ratio of
such amounts for 2025 was 0.3:1.
Our methodology for identifying our median compensated employee for 2025 was as follows:
We determined that, as of December 31, 2025, Axon and all of our subsidiaries had 5,146 qualifying individuals
(full-time, part-time, and temporary employees other than Mr. Smith), of which 20% were based outside of the
United States and 14% were production-line employees.
We did not include in the population of qualifying individuals any contractors employed through third-parties.
We applied the requirements and assumptions required for the Summary Compensation Table for each such
individual as if he or she was a named executive officer to calculate total annual compensation, including base
salary or wages, performance-based commission payments, and equity awards based on their grant date fair
values.
We converted any payment earned or paid in a foreign currency to U.S. dollars using the average of the prevailing
conversion rates for 2025.
We selected the median of all total annual compensation amounts calculated in accordance with the foregoing.
The SEC rules for identifying the median compensated employee and calculating the pay ratio based on that employee’s
annual total compensation allow companies to adopt a variety of methodologies, exclusions and assumptions that reflect
their compensation practices. As such, the pay ratio reported above may not be comparable to the pay ratio reported by
other companies, even those in a related industry or of a similar size and scope. Other companies may have different
employment practices, regional demographics or may utilize different methodologies, exclusions and assumptions in
calculating their pay ratios.
Axon Enterprise, Inc. | 2026 Proxy Statement | 60
Table of Contents
AUDIT MATTERS
REPORT OF THE AUDIT COMMITTEE
The Audit Committee of the Board of Directors reviews the Company’s financial reporting process on behalf of the Board.
The Audit Committee has sole authority to retain, set compensation and retention terms for, terminate, oversee and evaluate
the work of the Company’s independent registered public accounting firm (the “independent auditor”). The independent
auditor reports directly to the Audit Committee.
The Company’s management is responsible for the Company’s financial reporting process, including its system of internal
controls, and for the preparation of consolidated financial statements in accordance with accounting principles generally
accepted in the United States. PricewaterhouseCoopers LLP, the Company’s independent auditor, is responsible for
expressing an opinion based on its audits of the consolidated financial statements and for performing an independent audit
of our internal control over financial reporting and expressing an opinion thereon.
In accordance with its written charter, the Audit Committee assists the Board of Directors in fulfilling its oversight
responsibilities regarding (i) the Company’s process for financial reporting and the integrity of the Company’s financial
statements; (ii) the Company’s internal control system; (iii) the performance of the Company’s internal audit function; (iv)
the independent auditor’s independence, qualifications and performance; (v) the Company’s risk assessment and
management policies for major financial risks; and (vi) the Company’s Code of Business Conduct and Ethics and process
for monitoring compliance with laws and regulations.
Further, the Audit Committee reviews reports prepared by management on various matters, including critical accounting
policies and issues, material written communications between the independent auditor and management, significant
changes in the Company’s selection or application of accounting principles and significant changes to internal control
procedures. It is not the duty or responsibility of the Audit Committee to conduct auditing and accounting reviews or
procedures.
In discharging its oversight responsibilities with respect to the audit process, the Audit Committee (i) obtained from the
independent auditor a formal written statement describing all relationships between the independent auditor and the
Company that might bear on the independent auditor’s independence consistent with the applicable requirements of the
Public Company Accounting Oversight Board (“PCAOB”), (ii) discussed with the independent auditor any relationships
that may impact its objectivity and independence, and (iii) considered whether any non-audit services provided to the
Company by PricewaterhouseCoopers LLP are compatible with maintaining its independence. The Audit Committee also
discussed with the independent auditor its identification of audit risk, audit plans and audit scope, as well as all
communications required by generally accepted auditing standards, including those described in Auditing Standard No.
1301, “Communications with Audit Committees” issued by the PCAOB.
The Audit Committee reviewed and discussed with management and its independent auditor the Company’s audited
consolidated financial statements and its internal control over financial reporting.
During 2025, the Audit Committee met with representatives of the independent auditor, both with management present and
in private sessions without management present, to discuss the results of the financial statement audit and quarterly reviews
and to solicit its evaluation of the Company’s accounting principles, practices and judgments applied by management and
the quality and adequacy of the Company’s internal controls.
In performing the above described functions, the Audit Committee acts only in an oversight capacity and necessarily relies
on the work and assurances of the Company’s management and independent auditor, which, in the independent auditor’s
report, expresses an opinion on the conformity of the Company’s consolidated financial statements to accounting principles
generally accepted in the United States.
Axon Enterprise, Inc. | 2026 Proxy Statement | 61
Table of Contents
Based upon the Audit Committee’s discussion with the Company’s management and PricewaterhouseCoopers LLP, and
the Audit Committee’s review of the representations of the Company’s management and the report of the independent
auditor to the Audit Committee, the Audit Committee recommended to the Board that the audited consolidated financial
statements be included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025.
The Audit Committee:
Graham Smith, Chair
Michael Garnreiter
Caitlin Kalinowski
Todd Morgenfeld
The foregoing Report of the Audit Committee does not constitute soliciting material and will not be deemed to be filed or
incorporated by reference by any general statement incorporating by reference this proxy statement into any other
Company filing under the Securities Act or Exchange Act, except to the extent the Company specifically incorporates this
Report by express reference therein.
Axon Enterprise, Inc. | 2026 Proxy Statement | 62
Table of Contents
PROPOSALS
Overview of Proposals
This proxy statement contains three proposals requiring shareholder action.
Proposal No. 1 requests the election of the 9 directors of the Company named in this proxy statement for a term of
one year and until their successors are elected and qualified.
Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the
Company’s named executive officers.
Proposal No. 3 requests the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s
independent registered public accounting firm for fiscal year 2026.
Each proposal is discussed in more detail below.
Axon Enterprise, Inc. | 2026 Proxy Statement | 63
Table of Contents
PROPOSAL NO. 1 - ELECTION OF DIRECTORS
The Board is elected by and accountable to the shareholders to oversee their interest in the long-term health and the overall
success of the Company’s business and its financial strength. The Board serves as the ultimate decision-making body of the
Company except for those matters reserved to, or shared with, the shareholders. The Board selects and oversees the
members of senior management, who are charged by the Board with conducting the business of the Company.
Election Process
The Board has nominated for election the following nine nominees: Erika Ayers Badan, Adriane Brown, Michael
Garnreiter, Caitlin Kalinowski, Todd Morgenfeld, Hadi Partovi, Graham Smith, Patrick Smith and Jeri Williams.
The Board has no reason to believe that any of the nominees will be unwilling or unable to serve if elected a director. If any
nominee is unable or unwilling to serve as a director at the date of the Annual Meeting or any postponement or
adjournment thereof, the proxies may be voted for a substitute nominee, as designated by the Board to fill such vacancy.
Unless otherwise instructed, all proxies received will be voted FOR the election of each of the nominees.
The Board of Directors recommends a vote FOR the election of Erika Ayers Badan, Adriane Brown, Michael
Garnreiter, Caitlin Kalinowski, Todd Morgenfeld, Hadi Partovi, Graham Smith, Patrick Smith and Jeri Williams.
Vote Required
For Proposal No. 1, under our Bylaws, assuming the existence of a quorum at the Annual Meeting, each director will be
elected by the affirmative vote of a majority of votes properly cast for and against such nominee’s election. Abstentions
and broker non-votes will be counted toward a quorum, but will not affect the outcome of the vote on the election of
directors.
Axon Enterprise, Inc. | 2026 Proxy Statement | 64
Table of Contents
PROPOSAL NO. 2 – ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S
NAMED EXECUTIVE OFFICERS
Shareholders will be given the opportunity to vote on the following advisory resolution (commonly referred to as “say on
pay”):
RESOLVED, that the shareholders of Axon Enterprise, Inc. hereby approve the compensation paid to the Company’s
NEOs, as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis,
compensation tables and narrative discussion set forth in this proxy statement.
Background on Proposal
In accordance with the requirements of Section 14A of the Exchange Act and related SEC rules, shareholders are being
given the opportunity to vote at the Annual Meeting on this advisory resolution regarding the compensation of our NEOs.
As described in the Compensation Discussion and Analysis, our executive compensation program is designed to allow us
to attract and retain market competitive talent, link annual incentive compensation to our financial results produced during
the year, and link long term compensation in the form of stock awards to Company performance and enhancement of
shareholder value over time. For a comprehensive description of our executive compensation program, philosophy and
objectives, including the specific components of executive compensation that comprised the program in 2025, please refer
to “Executive Compensation—Compensation Discussion and Analysis.” The 2025 Summary Compensation Table and
other executive compensation tables (and accompanying narrative disclosures) provide additional information about the
compensation that we paid to our NEOs in 2025.
At our 2023 Annual Meeting of Shareholders, the shareholders indicated, on an advisory vote basis, that they preferred that
we hold say-on-pay votes on an annual basis (a frequency vote is required to be held at least once every six years). In light
of these results, the Company’s Board of Directors decided to hold its future advisory votes on the compensation of named
executive officers annually.
Effects of Advisory Vote
Because the vote on this proposal is advisory in nature, it will not affect any compensation already paid or awarded to our
NEOs and will not be binding on the Board or the Compensation Committee. However, the Compensation Committee will
consider the outcome of the vote when making future executive compensation decisions.
Overview and Summary; Consideration of Prior Year Say-on-Pay Vote
The Company believes in competitive compensation aligned with the values, objectives and financial performance of the
Company. Since 2018, a significant amount of our executives’ potential total compensation has been tied to performance.
The Compensation Committee considers the performance criteria for the Company’s performance-based compensation
challenging but achievable. Performance-based RSUs, cash incentive compensation program, and commission targets have
been achieved during 2019, 2020, 2021, 2022, 2023, 2024, and 2025. Considering our ongoing CEO Performance Award
and Employee XSP, compensation remains aligned with long-term Company performance.
At the 2025 Annual Meeting, we presented to shareholders, for advisory approval, the Company’s executive compensation
for 2024 (“Say-on-Pay Proposal”). Of the 61.3 million votes cast on the Say-on-Pay Proposal (excluding abstentions and
broker non-votes), over 65% were favorable for our Say-on-Pay Proposal. The Compensation Committee considered this a
favorable outcome and believed it conveyed our shareholders’ support of the Compensation Committee’s decisions and
existing executive compensation programs.
Our compensation opportunities for our named executive officers are predominantly delivered in the form of performance-
based awards, including equity-based awards, which are designed to promote incentives that are aligned with long-term
shareholder interests. It is the Compensation Committee’s intent that the total compensation for our NEOs be competitive
to attract and retain highly qualified individuals who are capable of making significant contributions critical to our long-
term success.
The Compensation Committee will continue to consider the results from this year’s and future advisory votes on executive
compensation.
Axon Enterprise, Inc. | 2026 Proxy Statement | 65
Table of Contents
Unless otherwise instructed, all proxies received will be voted FOR approval of the advisory vote on executive
compensation.
The Board of Directors unanimously recommends a vote FOR approval of the resolution set forth above approving
the compensation of our named executive officers.
Vote Required
For Proposal No. 2, assuming the existence of a quorum at the Annual Meeting, the affirmative vote of a majority of the
total votes properly cast for or against the proposal in person or by proxy at the Annual Meeting is required for approval,
on an advisory basis. Abstentions and broker non-votes will have no impact on this proposal if a quorum is present.
Axon Enterprise, Inc. | 2026 Proxy Statement | 66
Table of Contents
PROPOSAL NO. 3 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
The Audit Committee has appointed PricewaterhouseCoopers LLP, independent registered public accounting firm, to audit
the consolidated financial statements of the Company for the year ending December 31, 2026. PricewaterhouseCoopers
LLP has served as the independent registered public accounting firm for the Company since 2024. A representative from
PricewaterhouseCoopers LLP is expected to be present at the Annual Meeting and will have the opportunity to make a
statement and is expected to be available to respond to appropriate questions.
Change in Independent Registered Public Accounting Firm
Grant Thornton LLP (“Grant Thornton”) served as our independent registered public accounting firm from 2005 through
2024. On February 26, 2024, following the conclusion of a process managed by the Audit Committee, the Audit
Committee approved the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public
accounting firm, effective following the filing of the 2023 Annual Report. The Audit Committee views periodic auditor
rotation, particularly after a long tenure, as a good governance practice that supports auditor independence.
During the Company’s year ended December 31, 2023 and through February 26, 2024, neither the Company, nor anyone
on its behalf, consulted PricewaterhouseCoopers LLP regarding either: (i) the application of accounting principles to a
specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s
financial statements, and neither a written report nor oral advice was provided to the Company that
PricewaterhouseCoopers LLP concluded was an important factor considered by the Company in reaching a decision as to
any accounting, auditing, or financial reporting issue; or (ii) any matter that was the subject of a “disagreement,” within the
meaning of Item 304(a)(1)(iv) of Regulation S-K promulgated under the Exchange Act and the related instructions thereto
(“Regulation S-K”), or “reportable event,” within the meaning of Item 304(a)(1)(v) of Regulation S-K.
In connection with the appointment of PricewaterhouseCoopers LLP, on February 26, 2024, the Audit Committee
approved the dismissal of Grant Thornton LLP as the Company’s independent registered public accounting firm, effective
immediately following completion of their engagement for the year ended December 31, 2023.
The appointment of PricewaterhouseCoopers LLP did not affect Grant Thornton’s engagement for the year ended
December 31, 2023.
During the year ended December 31, 2023 and the subsequent interim period through February 26, 2024, there were no: (1)
“disagreements,” within the meaning of Item 304(a)(1)(iv) of Regulation S-K, between the Company and Grant Thornton
on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which
disagreements, if not resolved to Grant Thornton’s satisfaction, would have caused Grant Thornton to make reference to
the subject matter of the disagreement in connection with its report on the Company’s consolidated financial statements, or
(2) “reportable events,” within the meaning of Item 304(a)(1)(v) of Regulation S-K.
The audit report of Grant Thornton on the Company’s consolidated financial statements as of and for the year ended
December 31, 2023 did not contain an adverse opinion or a disclaimer of opinion, and was not qualified or modified as to
uncertainty, audit scope or accounting principles.
Shareholder ratification of the selection of PricewaterhouseCoopers LLP as our independent registered public accounting
firm is not required by our Bylaws or otherwise. Nonetheless, the Board, upon the recommendation of the Audit
Committee, is submitting the selection of PricewaterhouseCoopers LLP to the shareholders for ratification as a matter of
good corporate practice and because the Board and the Audit Committee value the views of our shareholders on our
independent auditors.
Even if the selection is ratified, the Audit Committee, in its discretion, may appoint a different independent registered
public accounting firm at any time during the year if it determines that such an appointment would be in the Company’s
best interest.
Axon Enterprise, Inc. | 2026 Proxy Statement | 67
Table of Contents
If the appointment is not approved by the shareholders, the adverse vote will be considered a direction to the Audit
Committee to consider other auditors for next year. However, because of the difficulty in making any substitution of
auditors so long after the beginning of the current year, the appointment in 2026 will stand, unless the Audit Committee
finds other good reason for making a change.
Audit and Non-Audit Fees
The following table presents fees for audit, tax and other professional services rendered by PricewaterhouseCoopers LLP 
for the years ended December 31, 2025 and December 31, 2024.
2025
2024
Audit fees (1)
$4,789,477
$3,963,000
Audit-related fees (2)
105,000
145,000
Tax fees (3)
All other fees (4)
2,000
2,000
$4,896,477
$4,110,000
______________________________________
(1)Audit Fees: Consists of fees billed for professional services rendered for the audit or review of Axon Enterprise, Inc.’s
consolidated financial statements, fees billed related to Sarbanes-Oxley 404 review, and related services provided by
PricewaterhouseCoopers LLP for the years ended December 31, 2025 and December 31, 2024.
(2)Audit-Related Fees: Consists of internal control and system review procedures.
(3)Tax Fees: No tax consulting and planning services were rendered during the years ended December 31, 2025 or 2024.
(4)All Other Fees: Consists of licenses for disclosure software for the years ended December 31, 2025 and December 31,
2024.
Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditor
Consistent with SEC policies regarding auditor independence, the Audit Committee must pre-approve all audit and
permissible non-audit services provided by our independent auditors. Our Non-Audit Services Pre-Approval Policy covers
all services to be performed by our independent auditors. The policy contemplates a general pre-approval for all audit,
audit-related, tax and all other services that are permissible, with a general pre-approval period of twelve months from the
date of each pre-approval. Any other proposed services that are to be performed by our independent auditors, not covered
by or exceeding the pre-approved levels or amounts, must be specifically approved in advance.
The Audit Committee has considered and concluded that the provision by PricewaterhouseCoopers LLP of non-audit
services is compatible with PricewaterhouseCoopers LLP maintaining its independence.
Unless otherwise instructed, all proxies received will be voted FOR ratification of the appointment of
PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026.
The Board of Directors recommends a vote FOR ratification of the appointment of PricewaterhouseCoopers LLP as
the Company’s independent registered public accounting firm for fiscal year 2026.
Vote Required
For Proposal No. 3, assuming the existence of a quorum at the Annual Meeting, the affirmative vote of a majority of the
total votes properly cast for or against the proposal in person or by proxy at the Annual Meeting is required for ratification.
Abstentions will have no impact on this proposal if a quorum is present.
Axon Enterprise, Inc. | 2026 Proxy Statement | 68
Table of Contents
OTHER MATTERS
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Statements contained in this proxy statement that are not historical are “forward-looking statements” within the meaning of
Section 27A of the Securities Act and Section 21E of the Exchange Act, including statements regarding our expectations,
beliefs, intentions and strategies regarding the future. We intend that such forward-looking statements be subject to the
safe-harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements give our current
expectations or forecasts of future events; they do not relate strictly to historical or current facts. Words such as “may,”
“will,” “estimate,” “project,” “plan,” “potential,” “continue,” “future,” “intend,” “expect,” “anticipate,” “believe,” “would,”
“should,” “could” and similar expressions are intended to identify forward-looking statements. However, not all forward-
looking statements contain these identifying words.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our
plans and assumptions. Achievement of future results is subject to risks, uncertainties and potentially inaccurate
assumptions. Many events beyond our control may determine whether results we anticipate will be achieved. Should
known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results
could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you
consider forward-looking statements. These factors are intended as cautionary statements for investors within the meaning
of Section 27A of the Securities Act and Section 21E of the Exchange Act. Important factors that could cause actual results
to differ materially from those indicated by such forward-looking statements include those set forth in Axon’s filings with
the SEC, including the 2025 Annual Report, which accompanies this proxy statement. You should understand that it is not
possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of
all potential risks or uncertainties.
Except as required by law, we undertake no obligation to publicly update forward-looking statements, whether as a result
of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on
related subjects in our Form 8-K, 10-Q and 10-K reports to the SEC. Our filings with the SEC may be accessed at the
SEC’s web site at www.sec.gov.
DELINQUENT SECTION 16(A) REPORTS
Section 16(a) of the Exchange Act requires our directors and officers, and holders of more than 10 percent of our common
stock to file with the SEC reports regarding their ownership and changes in ownership of our common stock and other
equity securities of the Company. We believe that, during the year ended December 31, 2025, all such reports that were
required to be filed under Section 16(a) were timely filed, except for (i) one report relating to securities withheld on June 2,
2025 to settle the tax liability resulting from the vesting of certain RSUs for Jennifer Mak (Principal Accounting Officer),
and (ii) one report relating to the certification of achievement of performance conditions for the first and second tranches of
XSUs on August 28, 2025 for Mr. Brooks. In making such statement, we have relied upon examination of the copies of
Forms 3, 4, and 5 provided to us and the written representations of our directors and executive officers.
SHAREHOLDER PROPOSALS
To be eligible for inclusion in the Company’s proxy materials for the 2027 Annual Meeting of Shareholders, a proposal
intended to be presented by a shareholder for action at that meeting must, in addition to complying with the shareholder
eligibility and other requirements of the SEC’s rules governing such proposals, be received not later than December 17,
2026 by the Corporate Secretary of the Company at the Company’s principal executive offices, 17800 North 85th Street,
Scottsdale, Arizona 85255.
Axon Enterprise, Inc. | 2026 Proxy Statement | 69
Table of Contents
Shareholders may bring business before an annual meeting of shareholders that is not submitted for inclusion in the
Company’s proxy materials pursuant to the process set forth above (including the nomination of any person to be elected as
a director) only if the shareholder proceeds in compliance with the Company’s Bylaws. For business to be properly brought
before an annual meeting of shareholders by a shareholder that is not submitted for inclusion in the Company’s proxy
materials (including the nomination of any person to be elected as a director), shareholders are advised to review the
Company’s Bylaws as they contain requirements with respect to advance notice of proposed business. To be timely, in
accordance with the Company’s Bylaws, notice must be delivered to the Corporate Secretary of the Company in proper
written form not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year’s annual
meeting. Accordingly, any such shareholder proposal or director nomination must be received between January 28, 2027
and February 27, 2027 for the 2027 Annual Meeting of Shareholders. In the event that the date of the 2027 Annual Meeting
of Shareholders is more than 30 days before or more than 60 days after May 28, 2027, notice by the shareholder, to be
timely, must be so delivered no later than the close of business on the 90th day prior to the date of the 2027 Annual
Meeting of Shareholders and the 10th day following the day on which public announcement of the date of the 2027 Annual
Meeting of Shareholders is first made by the Company. In addition to satisfying the foregoing advance notice deadlines and
information requirements set forth in the Company’s Bylaws, any shareholder intending to submit a nomination for director
to the Board other than the Company’s nominees must comply with the additional requirements prescribed by Rule 14a-19
under the Exchange Act.
The presiding officer at any annual meeting will determine whether any matter was properly brought before the meeting in
accordance with the above provisions. If the presiding officer should determine that any matter has not been properly
brought before the meeting, he or she will so declare at the meeting and any such matter will not be considered or acted
upon.
HOUSEHOLDING OF ANNUAL MEETING MATERIALS
Some brokers and other nominee record holders may be participating in the practice of “householding” proxy statements
and annual reports. This means that only one copy of this proxy statement and 2025 Annual Report may have been sent to
multiple shareholders in a shareholder’s household. The Company will promptly deliver a separate copy of either document
to any shareholder who contacts the Company’s investor relations department at 17800 North 85th Street, Scottsdale,
Arizona 85255, phone number (480) 515-6330, requesting such copies. If a shareholder is receiving multiple copies of this
proxy statement and 2025 Annual Report at the shareholder’s household and would like to receive a single copy of the
proxy statement and annual report for a shareholder’s household in the future, shareholders should contact their broker,
other nominee record holder, or the Company’s investor relations department to request mailing of a single copy of the
proxy statement and annual report.
A copy of the Company’s 2025 Annual Report is available to shareholders without charge upon request to: Investor
Relations, Axon Enterprise, Inc., 17800 North 85th Street, Scottsdale, Arizona 85255.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY
MATERIALS FOR THE ANNUAL SHAREHOLDER MEETING TO BE HELD ON MAY 28, 2026
The proxy materials for the Company’s Annual Meeting of Shareholders, including the 2025 Annual Report and this proxy
statement, are available over the Internet by accessing the investor relations page of the Company’s website at http://
investor.axon.com. Other information on the Company’s website does not constitute part of the Company’s proxy
materials.
By Order of the Board of Directors,
/s/ ISAIAH FIELDS
Isaiah Fields
Corporate Secretary
April 16, 2026
Axon Enterprise, Inc. | 2026 Proxy Statement | 70
Table of Contents
Reconciliation of Non-GAAP Measures
(in thousands)
To supplement our financial results presented in accordance with accounting principles generally accepted in the United
States (“GAAP”), we present the non-GAAP financial measures of EBITDA and adjusted EBITDA as defined below.
Management uses these non-GAAP financial measures in making operating decisions, allocating financial resources and
evaluating our performance in comparison to prior periods. We believe that both management and investors benefit from
referring to these non-GAAP financial measures in assessing our performance, and when planning and forecasting our
future periods. A reconciliation of GAAP to the non-GAAP financial measures are presented below.
EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense, investment interest
income, income taxes, depreciation and amortization.
Adjusted EBITDA (most comparable GAAP measure: Net income) – Earnings before interest expense;
investment interest income; income taxes; depreciation; amortization; noncash stock-based compensation expense;
fair value adjustments related to strategic investments, marketable securities, and mark-to-market on our non-
qualified deferred compensation liabilities; debt inducement expense associated with the early repurchase of a
portion of our 2027 Notes; non-recurring severance costs, including employee cash payments, equity, and related
benefits; transaction and integration costs related to strategic investments and acquisitions, including the change in
fair value of contingent consideration arrangements; payroll taxes related to Employee XSP vesting and 2018
CEO Performance Award option exercises; costs (or subsequent recoveries of prior costs) related to certain legal
or regulatory matters we consider outside of our core operating activities; losses incurred as a result of the
disposal, abandonment, and impairment of property, equipment and intangible assets; inventory step-up
amortization related to acquisitions; and loss recoveries.
Adjusted EBITDA margin (most comparable GAAP measure: Net income margin) – Adjusted EBITDA as a
percentage of Net sales. Adjusted EBITDA and adjusted EBITDA margin reconcile to Net income and Net
income margin, respectively.
Axon Enterprise, Inc. | 2026 Proxy Statement | 71
Table of Contents
Year Ended December 31,
2025
2024
2023
2022
2021
Net income
$124,656
$377,034
$175,783
$146,930
$(56,339)
Depreciation and amortization
86,789
56,815
32,638
24,381
18,694
Interest expense
94,238
7,098
6,995
488
28
Investment interest income
(75,431)
(43,693)
(49,107)
(4,782)
(1,511)
Provision for (benefit from) income taxes
(105,682)
4,470
(18,722)
49,308
(80,062)
EBITDA
$124,570
$401,724
$147,587
$216,325
$(119,190)
Non-GAAP adjustments:
Stock-based compensation expense
$610,151
$382,604
$131,358
$106,176
$303,331
Unrealized and realized losses (gains) on
investments and marketable securities, net
(134,658)
(189,277)
41,785
(98,943)
(23,035)
Realized (gains) on previously held minority
interests acquired in business combinations, net
(2,193)
(93,940)
Debt inducement expense
38,868
Severance costs
31,816
Transaction costs related to strategic investments
and acquisitions
15,588
15,249
4,501
2,368
2,068
Payroll taxes related to Employee XSP vesting
and 2018 CEO Performance Award option
exercises
14,768
2,645
9,011
18,933
Litigation and regulatory costs
9,579
1,761
241
545
741
Loss on disposal, abandonment, and impairment
of property, equipment and intangible assets, net
1,059
317
5,562
238
Inventory step-up amortization
607
609
Loss recoveries
(3,404)
Adjusted EBITDA
$710,155
$521,375
$331,396
$232,033
$183,086
Net sales
$2,779,536
$2,082,526
$1,560,699
$1,187,143
$865,638
Net income as a percentage of net sales
4.5%
18.1%
11.3%
12.4%
(6.5)%
Adjusted EBITDA margin (adjusted EBITDA as a
percentage of net sales)
25.5%
25.0%
21.2%
19.5%
21.2%
Table of Contents
Proxy Card - Page 1.jpg
Table of Contents
Proxy Card - Page 2.jpg

FAQ

What will Axon (AXON) shareholders vote on at the 2026 annual meeting?

Shareholders will vote on electing the directors named in the proxy, an advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026, all at a fully virtual meeting.

How did Axon (AXON) perform financially in 2025 according to the proxy?

Axon reports record 2025 revenue of $2.8 billion, up 33% year over year, its fourth consecutive year of 30%+ growth. Net income was $125 million and adjusted EBITDA reached $710 million, reflecting a 25.5% margin while the company continued to invest heavily in R&D and expansion.

What recurring revenue metrics does Axon (AXON) highlight in the filing?

The proxy notes annual recurring revenue of $1.3 billion and net revenue retention of 125%. Software & Services grew over 40% and now represent 43% of total revenue, underscoring Axon’s shift toward subscription and cloud-based offerings that support long-term, contracted customer relationships.

What governance practices does Axon (AXON) emphasize in its 2026 proxy statement?

Axon highlights independent board leadership, a majority independent board, annual director elections, majority voting in uncontested elections, proxy access, and limits on outside board service. Committees oversee audit, compensation, ESG, enterprise risk, cybersecurity, AI governance, and mergers and acquisitions.

How strong are Axon’s (AXON) shareholder returns compared with the S&P 500?

The proxy states that Axon ranks above the 93rd percentile among all S&P 500 companies for three-, five- and ten-year total shareholder returns. This places the company among the index’s top long-term performers over multiple time horizons, based on stock price performance through December 31, 2025.

What AI and technology initiatives does Axon (AXON) describe in the proxy?

Axon describes an AI-focused ecosystem built around TASER devices, body cameras, sensors and its Evidence.com platform. It highlights Axon Assistant, used by more than 500 agencies, AI-enhanced VR training, Axon Vehicle Intelligence, Axon Body Mini, and Axon 911, all designed to integrate real-time data and workflows.

How many Axon (AXON) shares are entitled to vote at the 2026 annual meeting?

The proxy states that 80,572,201 shares of Axon’s common stock were outstanding as of March 31, 2026, the record date. Each share carries one vote on all matters presented, and shareholders may vote online, by telephone or by mail using their unique 16-digit control number.